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ABSTRACT
DENERVATION SUPERSENSITIVITY OF THE RAT VAS DEFERENS: 
A ROLE FOR PROTEIN KINASE C 
by
Sonny Thomas Abraham
A role for protein kinase C (PKC) in the denervation-induced supersensitivity 
of the rat vas deferens was investigated. Chronict surgical denervation of the rat vas 
deferens (up to 8 days) resulted in tissues that produced enhanced contractile responses 
to norepinephrine (NE) in isolated organ baths. Single challenges of NE (10 pM) 
produced 0.6 ±0.1 g of maximal tension in the control vas whereas in the paired, 
denervated tissue 2.2 ± 0.3 g of tension was recorded (n-6). Cumulative 
concentration-effect curves to NE produced in the denervated vas deferens were 
shifted 18-fold to the left of the control response. Neurokinin A (NKA) responses 
after denervation of the tissue were not significantly different from the control. 
Denervation did not alter the contractile response to phorbol diacetate (PDA), a PKC 
activator. Pretreatment of denervated and control vas deferens with 100 pM 
nifedipine (a calcium channel blocker), significantly attenuated the contractile response 
to NE. The responses in the control tissues were depressed by 88%, those in the 
denervated vasa were only antagonized by 65% after nifedipine treatment.
Exposure of denervated and control vas deferens to 100 pM NE resulted in no 
significant accumulation of diacylglycerol (DAG) from basal values. The molecular 
species of DAG produced after receptor stimulation, in either tissue group, were not 
different from those found in resting tissues. Denervation also had no effect on the 
binding characteristics of membrane-associated PKC when assayed using the specific 
ligand, pHJphorbol dibutyrate. Binding maxima of 4.8 ± 0.9 and 4.1 ± 0.4 pmol/mg 
protein (n-4) were determined in the membrane fraction isolated from paired control 
and denervated vas deferens, respectively. The dissociation constant for the ligand 
was found to be 4.3 ± 0.6 and 3,5 ± 0.1 nM in the control and denervated groups, 
respectively.
The PKC activity of resting vas deferens was not altered by chronic surgical 
denervation, Denervated and control vas deferens that were stimulated with 100 pM 
NE showed a time-dependent translocation of PKC from the cytosolic to the 
membrane fraction of the tissue. In both tissue groups exposure to NE resulted in a 3- 
4 fold increase in the membrane-bound PKC activity, which remained elevated above 
basal values for up to 20 mln. The rate of translocation of PKC was faster in 
denervated vasa (maximal at 5 min after NE) when compared to the control (maximal
iii
at 20 min), but the maximal amount of the enzyme activated was the same for the two 
tissue groups. The ability of NKA, 60 mM Kf-depoIarization and PDB (PKC 
activator) to produce translocation of the PKC was not altered by denervation of the 
vas deferens.
In conclusion, surgical denervation of the rat vas deferens produced tissues that 
exhibited enhanced contractile activity when exposed to NE but not NKA. The 
apparent resistance of the denervated tissue to calcium channel blockade (with 
nifedipine) may indicate either an enhanced sensitivity of the contractile apparatus to 
Ca2* or a decreased dependence of the tissue on extracellular CaIf after denervation. 
The unaltered basal DAO or PKC levels after denervation would indicate that the 
supersensitive response is not due to their elevation under resting conditions.
However, the increased rate of activation of PKC in denervated tissue, in response to 
NE, is consistent with a positive role for the enzyme in the enhanced contractile 
activity of the rat vas deferens.
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CHAPTER 1
Introduction
Survey of Supersensitivitv in Various Organs 
The first report of denervation-induced supersensitivity appeared in 1855 when 
Budge observed a greater pupillary dilation of irides after sectioning of the 
postganglionic fibers from the superior cervical ganglia as compared with sectioning 
the preganglionic fibers cited by (Fleming et al„ 1973). A mechanism for this 
phenomenon was not described until about fifty years later when Langendorff 
discovered that the "paradoxical" dilation of the denervated iris (postganglionic nerve 
sectioned) versus the decentralized iris (preganglionic nerve sectioned) was due to 
circulating substances from the adrenal glands. This phenomenon is now known to be 
due to enhanced sensitivity of denervated irides to circulating catecholamines released 
from the adrenal medulla (Fleming et al., 1973).
Thesleffe and others (Thesleffe, 1960) reported the development of 
supersensitivity of skeletal muscle when denervation resulted in greatly enhanced 
contractile response to acetylcholine (ACh). The area of the muscle sensitive to ACh, 
which is normally confined to the motor end-plate, spread outward to cover the entire 
surface of the muscle fiber. Electrophysiological and radiolabelled studies indicated a 
spread in nicotinic receptors horn the end-plate region to cover the entire surface of 
the muscle (Fleming et al., 1973; Askmark and Gillberg, 1987). The increase in the 
number of nicotinic receptors, as determined by binding studies, after denervation
(Askmark and Gillberg, 1987) was corroborated by reports of increased mRNA for the 
a-subunit of the receptor protein after denervation (Shieh et al.t 1987). These findings, 
however, did not entirely explain the resulting contractile response of denervated 
skeletal muscle to non-cholinergic agents (e.g. histamine, serotonin, bradykinin and 
caffeine) which are not seen in normally innervated muscle.
Westfall and Fleming (1968a) showed that chronic catecholamine depletion of 
adrenergic nerves by reserpine resulted in enhanced sensitivity of cardiac muscle to the 
chronotropic effects of norepinephrine and calcium in the dog as well as the guinea 
pig (Westfall and Fleming, 1968b). However, changes in the inotropic effect of 
various agonists after reseTpine treatment was not consistently seen. Chronic reserpine 
treatment of the rat has also been shown to produce enhanced chronotropic sensitivity 
of spontaneously beating right atria to isoproterenol (Rice et al., 1987).
Denervation studies have also been conducted in a number of smooth muscle 
organs from various species. Trendelenberg (1963) and Langer (1966) describe 
extensive work done in producing sensitivity changes in the cat nictitating membrane 
by reserpine treatment or sectioning of the preganglionic fibers innervating the organ. 
Akhtar and Abdel-Latif (1986) were able to denervate the iris by surgically removing 
the superior cervical ganglion in the rabbit. In isolated organ baths denervated irides 
were 17-fold more sensitive to the contractile effect of NE as control tissues.
Chronic treatment of guinea pigs with the ganglionic blocking agent 
chlorisondamine resulted in increased sensitivity of the isolated ileum to acetylcholine 
(Fleming, 1968). The production of supersensitivity in vascular smooth muscle after
3adrenergic neurotransmitter depletion with reserpine has been observed less 
consistently . This is probably due to the fact that changes in sensitivity were usually 
measured in the intact animal where difficulty in delineating purely postjunctional 
responses was encountered. Oranges in resting blood pressure, basal adrenergic tone, 
and uptake and metabolism of pressor agents that often results from reserpine 
treatment may account for much of the inconsistency (Fleming et al., 1973).
Supersensitivitv of the Rat Vas Deferens.
Birmingham (1968) showed that stripping the serous coat around the vas 
deferens caused a loss of NE content as well as catecholamine fluorescence in the 
tissue eight days after the procedure. Vas deferens denervated in this manner 
exhibited about a 20-fold increase in sensitivity to the contractile stimulus of NE in 
vitro,
Kasuya et al. (1969) were able to produce supersensitivity in the rat vas 
deferens by destroying the hypogastric plexus from which short postganglionic fibers 
innervate the vas deferens (Sjostrand, 1965), This was achieved by crashing the 
hypogastric nerve plexus and stripping the serous coat from the most prostatic end of 
the vas (before the deferential artery meets the body of the vas deferens). This 
method had the advantage of causing less bleeding of the tissue when compared to the 
method of Birmingham (1968). Vasa denervated in this manner also showed marked 
loss in NE content and catecholamine fluorescence four days after the procedure, 
implying a nearly complete destruction of adrenergic nerves in the tissue. In vitro,
these tissues showed a greatly enhanced contractile response to NE that was 
characterized by significant leftward shifts in the concentration-effect (C-E) curve and 
increases in the maximal contractile force generated by the tissue. This denervation- 
induced supersensitivity was also exhibited by acetylcholine, angiotensin II, high 
potassium and barium. The authors concluded that surgical denervation produced a 
nonspecific supersensitivity of the vas deferens since a number of dissimilar agents 
revealed the enhanced sensitivity of the tissue.
Pharmacological destruction of adrenergic nerves with 6-hydroxydopamine was 
also shown to produce equivalent supersensitivity in the rat vas deferens as the 
surgical procedure (Westfall, 1977). In the same study chronic reserpine treatment 
produced more modest changes in sensitivity with smaller shifts in the NE 
concentration-effect curves without a change in the maximal force produced by the 
tissue.
Mechanisms of Sunersensitivitv in the Rat Vas Deferens
Westfall et al. (1977) made the initial observation of about 100% increase in 
nexal contacts between smooth muscle cells from denervated vas deferens but not 
reserpine-treated tissues, as compared to control vasa. The authors postulated 
increased intercellular coupling, via nexal contacts, would mediate the increased 
maximal contractile force in response to various agents. However such nexal contacts 
may be largely artifactual due to the preparative procedure used (permanganate- 
flxation) since Paton et al. (1976) did not observe any nexal junctions between cells
when the normal vas deferens was fixed with glutaraldehyde prior to electron 
microscopy.
The electrophysiological characteristics of the smooth muscle cells after 
denervation of the vas deferens were studied by Goto et at. (1978). This group 
reported no change in the resting membrane potential after denervation, however, a 6.5 
mV reduction in the threshold potential to depolarization (by an external electrode) 
was observed. Hie authors also measured the propagation of electrotonic potential 
through the tissue and found that the spread of excitation through denervated vasa was 
markedly improved when compared to control tissues. It was concluded that the 
denervation-induced change in threshold potential and electrical propagation would 
result in increased sensitivity of the tissue to agents that depolarize the cell membrane. 
The change in the electrical conduction of denervated tissues was also consistent with 
the authors* earlier observation of increased nexal contacts between cells in denervated 
vasa,
Since catecholamines initiate contractile response of the vas deferens by 
activating the a,-adrenoceptor, changes in receptor characteristics after chronic 
denervation were studied by Hata et al. (1981). Using [JH]WB4101 as a specific 
ligand for Or adrenoceptors these authors described a significant decrease in receptor 
number without a change in the affinity of the receptor, after chronic denervation of 
the vas deferens. However, the ability of epinephrine and phenylephrine to displace 
[3H]WB4101 binding was significantly enhanced in denervated vasa whereas that of 
phentolamine and ergotamine did not change, The authors concluded that an increased
affinity of a  ,-adrenoceptors for agonists (epinephrine, phenylephrine) but not 
antagonists (WB4101, phentolanune) resulted after denervation of the vas. Such an 
increase in agonist affinity for the receptor was proposed to mediate the observed 
supersensitivity.
Rice (1983) found no change in the a,-adrenoceptor population of rat vas 
deferens after denervation when assayed using [3H]WB4101 as the ligand. Further, the 
ability of Epi to displace bound [3H]WB4101 in denervated or control vasa was not 
found to be different. The reason for the discrepancy between these two studies is 
not readily apparent.
More evidence for a lack of denervation-induced change in receptor 
characteristics was presented by Abel et al. (1985) who found no difference in the a,- 
adrenoceptors from denervated and control tissues, This group used [,15I]BE2254 as a 
specific ligand for the receptor binding assay. The ability of NE to displace this 
ligand from its binding site was not different in the two tissue groups either. 
Additionally, these authors reported that neither the Kd of NE nor the number of 
receptors was altered by denervation when determined in intact vasa by the receptor- 
inactivation method of Furchgott (1966),
Evidence for post-receptor events mediating enhanced sensitivity after 
denervation was reported by Takenawa et al. (1983) who showed an increased 
accumulation of phosphatidic acid (PA) after NE stimulation in these tissues.
However, NE-lnduced hydrolysis of phosphatidylinositol-4,5-blsphosphate (PIP3) in 
denervated tissues was not significantly different from that in control vas. The authors
thought their results were consistent with a rote for phosphatidic acid in increasing 
calcium-influx into supersensitive cells thereby mediating enhanced contractile 
response to agonists. A role for PA in mediating influx of cations has been proposed 
by various groups in the past (Putney et al, 1980; Salmon and Honeyman, 1980), but 
is not well accepted currently. Thus the significance of increased accumulation of PA 
in denervated tissues after receptor stimulation remains to be determined.
A passible link between enhanced contractile response and increased calcium 
mobilization in denervated rat vas deferens was investigated by Minneman et al. 
(1988). In 18-day denervated vasa, NE was found to be 10-fold more potent in 
causing total pH] inositol phosphate accumulation when compared to control tissues. 
No difference in the maximal amounts of pH] IPs formed was noted between the two 
tissues, In the presence of uptake and metabolism inhibitors, control tissues showed 
an equivalent increase in potency to NE-induced production of [}H]IPs as in the 
denervated group. The authors reasoned that the increased potency of NE in causing 
IP formation after denervation was due to loss of uptake and metabolism of 
exogenously applied NE (prejunctional phenomenon). This was supported by findings 
that the potency of phenylephrine and carbachol (not subject to uptake and 
metabolism as NE) in elevating IP levels was unchanged after denervation. The 
conclusion was reached that chronic denervation of the rat vas deferens does not result 
in an enhanced coupling of a  ,-adrenoceptors to PIP2 hydrolysis.
sGeneral Considerations in the Production of Supersensitivilv
Slow Time-course of Development.
Structures that are denervated or depleted of neurotransmitter take a number of 
days before maximal supersensitivity results. Daily administration of reserpine for 7- 
14 days was required to see optimal sensitivity development in the cat nictitating 
membrane (Fleming and Trendelenburg, 1961). Supersensitivity was maximally 
expressed about 4 days after surgical denervation of the rat vas deferens (Kasuya et 
al., 1969).
NonspecificJjatute_oLthe_Enhanced Sensitivity.
Chronic reserpine treatment resulted in increased sensitivity of rabbit aortic 
strips to NE, acetylcholine and potassium (Hudgins and Fleming, 1966). Kasuya et al. 
(1969) reported that denervation of the rat vas deferens resulted in supersensitivity of 
the organ to various dissimilar contractile agents as well. This nonspecific nature of 
the change in sensitivity is good evidence for some common post-receptor alteration in 
the cells which results in enhanced sensitivity to a number of different contractile 
agents.
Preiunctional and.Eost junctional Suoersensitivitv.
Tissues which receive predominantly adrenergic innervation appear to produce 
different types of supersensitivity when denervated or depleted of transmitter with
9reserpine. Prejunctional supersensitivity is seen with catecholamines which are subject 
to neuronal uptake (Trendelenburg, 1966). Thus tissues lacking adrenergic nerve 
endings (denervated) or with impaired uptake into the nerve terminal (cocaine treated) 
would exhibit a decreased threshold for activation by NG simply due to increased 
concentration of agonist at the receptor. This would result in a leftward shift in the 
agonist concentration-effect curve. Postjunctional supersensitivity is independent of 
neuronal uptake and would be exhibited by adrenergic as well as non-adrenergic 
agents. The enhanced sensitivity to NE in the denervated vas deferens was observed 
as an 18-fold shift in the agonist C-E relationship as well as an increase in the 
maximal contractile response of the tissue (Abraham and Rice, 1992a). Using 
inhibitors of neuronal and extra-neuronal NE uptake (cocaine, hydrocortisone) and 
metabolism (U-0521) in normal tissue it was determined that prejunctional 
supersensitivity probably accounted for about a six-fold leftward shift in the NE C-E 
curve. The remaining three-fold shift in the NE C-E curve as well as the increase in 
the maximal contractile response appear to be due to postjunctional alteration in tissue 
sensitivity.
Excitation-Contraction Coupling in Smooth Muscle
The_Central_Role_Qf_Caicium
Early studies by Ringer (1883) showed the importance of calcium in muscle 
contraction when the isolated frog heart ceased to beat and became insensitive to
stimulation in isotonic sodium chloride solution. Addition of calcium chloride to the 
solution restored the spontaneous activity of the heart which was maintained for a 
prolonged period. Production of contractile activity in skeletal muscle fibers by 
intracellular application of calcium via micropipette was more direct evidence for a 
role for calcium ions in muscle contraction (Ebashi, 1980). A central role for calcium 
has also been shown in smooth muscle contraction (Bozler, 1969). Since then work 
by numerous laboratories has shown that the elevation in intracellular ftee calcium is 
the primary initiator of contractile activity in smooth muscle (Ramos et al., 1986).
As in skeletal muscle, smooth muscle has been shown to possess actin and 
myosin filaments but in less than parallel orientation with the cell. Unlike in skeletal 
muscle the Z-line which anchors actin and myosin filaments is missing and the fibers 
appear to be attached to cytoskeletal elements via dense bodies (Somlyo et al., 1977). 
The myosin isolated from various smooth muscle cells appears to be much like that in 
skeletal muscle, having one pair of heavy polypeptide chains (200 kDa M.W.) and two 
pairs of light chains (15-20 kDa).
Adelstein et al. (1977) described a cellular kinase which was able to 
phosphoiylate the light chains of smooth muscle myosin in the presence of calcium. 
They also showed that this light chain phosphorylation increased the ability of actin 
to stimulate the ATPase activity of the myosin head. From these results they proposed 
a model by which elevation in intracellular calcium above 0 .1-1 pM would activate 
myosin light chain kinase. This enzyme would in turn phosphoiylate the 20 kDa light 
chains of myosin resulting in actin-mediated ATPase activity of the myosin head with
II
subsequent actin-myosin crossbridge cycling and muscle contraction. With the 
discovery of a calcium binding protein (calmodulin) which activates MLCK, the 
cascade for production of contractile response can now be linked to elevations in 
cytoplasmic calcium (Kamm and Stull, 1985),
Contractile force in smooth muscle is thought to develop when the myosin 
head interacts with the actin filament and undergoes a conformational change at the 
"hinge" region of the heavy chain. This causes the myosin head to pull on the actin 
filament to produce a power stroke resulting in the myosin and actin filaments sliding 
past each other (Murphy, 1976). The energy for this stroke is derived from bound 
ATP which is hydrolyzed to ADP and P( by the slow ATPase activity of the myosin 
head. During the power stroke the bound ADP and Pf are released and this exposes 
the site for ATP binding which results in detachment of the myosin head from actin. 
Subsequent ATP hydrolysis returns the myosin head to the "cocked" state in position 
to interact with a new site on the actin filament further down its length and the cycle 
is repeated. This results in the myosin head "walking" along the actin filament and 
many such events in parallel eventually shorten the cell.
Coupling of Receptors to Calcium Mobilization
It is quite clear that intracellular Ca3* is the fundamental second messenger for 
the production of muscle contraction and it appears that receptor activation results in 
its mobilization (Michell, 1975). What remains to be determined is how cell-surface 
receptor stimulation results in this event. Since early observations of hormone-induced
12
phosphotnositide metabolism (Hokin and Holdn, 1953} it has become increasingly 
accepted that CaJ* mobilization by hormones is linked to this early membrane event. 
These receptors appear to be linked via guanine nucleotide binding proteins (G 
proteins) to a plasma-membrane bound phospholipase C which is able to hydrolyze 
membrane phospholipids, primarily phosphatidylinositol-4,5-bisphosphate (PIP2), to 
produce inositol-1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DAG) (Berridge, 
1984).
Evidence for a link between IP3 and Caa*-mobilization arose from work in 
permeabilized hepatic and pancreatic cells where IP3 was able to release cellular stores 
of Ca1* in a low calcium environment (Streb et al., 1983). This release of intracellular 
Ca1* was shown to be from non-mitochondrial, non-secretory granule microsomal 
fraction of cells and quite specific for IP3 since inositol-1,4-bisphosphate, inositol-1- 
phosphate or inositol-1,2-cyclic phosphate were not able to elicit this action.
Photolysis of caged IP3 by laser pulse has also been shown to produce contractile 
activity in smooth muscle (Walker et at., 1987). A role for other inositol 
polyphosphates (IP4, IPj, etc.) in CaJ>-mobilization from extracellular sources has also 
been proposed but remains without firm supportive evidence.
In the rat vas deferens, Fox et al. (1985) showed that concentration-dependent 
activation of a  (-adrenoceptors by NE resulted in significant inositol phosphate 
accumulation. It was also reported that partial agonists which were only able to 
produce 60% or less of the contractile response of NE were able to elicit 70-98% of 
the NE-induced IP accumulation. The same group (Han et al., 1987) also published a
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report showing that incubation of the vas with a,-adrenoceptor antagonists WB4101 
and benoxathian prior to NG exposure inhibited the contractile activity of the vas to a 
greater extent than it did the elevation in IPs.
This dissociation of inositol phosphate accumulation from contractile response 
revealed by partial agonists and antagonists was used by the authors to postulate two 
distinct subtypes of a,-adrenoceptor, one which appears to mediate contractile 
response (a lb-type) and the other coupled to PIP2 hydrolysis (a,,-type). Additionally 
the same paper showed that the normal vas deferens was very dependent on 
extracellular Ca2* for the production of contractile force in response to NE. These 
results taken together make the physiological role of IP3 in mediating contractile 
response in the vas deferens rather ambiguous. To explain such discrepancies Putney 
(1986) and Irvine and Moore (1986) have proposed models in which release of 
intracellular Ca3f promotes influx of Ca3* to maintain high enough cytosolic Ca2* to 
mediate cellular response as well as to refill depleted intracellular stores.
The Role of Protein Kinase C
A role for 1,2-diacylglycerol (DAG), produced as a result of PIP2 hydrolysis 
(Fig. 1), was first proposed by Nishizuka's group who showed that protein kinase C 
(PKQ was dependent on unsaturated diacylglycerol for activation (Takai et al., 1979). 
They were able to show that PKC was activated during thrombin stimulation of 
platelets resulting in phosphorylation of specific intracellular proteins (Kawahara et al., 
1980). Since then PKC has been identified in almost all cell types and found to
perform multiple functions (Nishizuka, 1988), The protein is found mostly in the 
cytosol in soluble form with smaller amounts associated with the plasma membrane, 
nuclear membrane and cytoskeletal filaments. This 82kDa protein possesses a 
regulatory domain which binds Ca1*, phosphatidylserine (PS) and DAG or phorbol 
esters as well as a catalytic domain which binds ATP.
fcCTPrtj*.
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Figure 1 Scheme for CaJ*-mobilization and contractile activity in smooth muscle. 
Gp, G-protein; PLC, phospholipase C; PIP2, phosphatidylinositol-4,5-bisphospliale; 
IP3, inositol-1,4,5-trisphosphate; DAG, 1,2-diacylglycerol; PKC, protein kinase C; 
MLCK, myosin light chain kinase; MLC, myosin light chain.
The enzyme functions optimally in the presence of DAG, PS and Ca1* which
results in the exposure of the catalytic domain to serine and threonine phosphorylation 
sites on substrate proteins (Bell and Bums, 1991). Phorbol esters (PDB, PMA etc.) 
appear to bind to the same site on PKC as DAG and thus are able to activate the 
enzyme in a manner similar to the endogenous activator (Konig et al.t 1985). During 
physiological stimulation cytosolic PKC is thought to become associated with the 
plasma membrane, where it is in proximity with PS and DAG in the presence of Ca2* 
(Huang; 1989). The primary stimulus for this translocation of PKC appears to be the 
rise in intracellular free Ca1* (Ho et al., 1988), however, others maintain that sustained 
elevation in membrane DAG may be responsible for PKC translocation (Rasmussen et 
al., 1987).
Molecular cloning techniques have identified several isozymes of PKC, most 
notably a, pi, pil, Y. 6* e, ft q and L, of which a - y  ate dependent on Ca1* for 
activity while 6 - L appear to be Ca1*-independent (Bell and Bums, 1991). Smooth 
muscle cells contain the Ca2*-dependent a , p and y  subtypes (Singer et al., 1992) as 
well as the Ca3*-independent e and (  isoforms (Khalil et al., 1992). The role of the 
various subtypes of PKC in smooth muscle is largely unknown although there does 
appear to be some differential activation of the different isoforms during receptor 
stimulation (Singer et al., 1992; Khalil et al., 1992).
Protein kinase C has been proposed to maintain sustained contraction of 
smooth muscle since: (i) PKC-mediated contractile response by phorbol esters (PDB) 
takes over an hour to develop maximally (Merkel et al., 1991); (ii) PKC-mediated 
phosphorylation of cellular proteins desmln, synemin and caldesmon appear after about
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phosphorylation of cellular proteins desmin, synemin and caldesmon appear after about 
1 hour of agonist stimulation. The role of PKC in smooth muscle has been proposed 
to be to phosphorylate these cellular proteins which may then play a role in 
modulating sustained muscle contraction (Rasmussen et al., 1987). However, a role 
for PKC in initiating and maintaining smooth muscle contraction has been presented in 
non-vascular smooth muscle (Menkes et al., 1986; Abraham and Rice, 1992b).
In intact iris smooth muscle Howe and Abdel-Latif (1988) have shown that 
PKC activation is able to phosphorylate myosin light chain (MLC) at a site distinct 
from that of myosin light chain kinase, The relevance of this action on muscle 
contraction is unknown but the phosphorylation of MLC preceded the production of 
contractile response in the tissue by phorbol dibutyrate (PDB). Lacerada et al. (1988) 
as well as Souhrada and Souhrada (1989) have shown that PKC activation can enhance 
Caa*-influx into muscle cells and have offered this as the mechanism by which PKC 
mediated contractile response occurs.
Statement of the Problem 
The work of numerous groups has shown that supersensitivity in smooth 
muscle results from the withdrawal of the endogenous neurotransmitter from the nerve 
endings in the tissue (Fleming et al., 1973). In the rat vas deferens the resulting 
supersensitivity is thought to be due to postjunctional alteration in the smooth muscle 
cells (Kasuya et al., 1969). However, work by various investigators has failed to 
provide clear evidence of cellular changes which would explain the nonspecific
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supersensitivity to dissimilar contractile agents.
The increase in nexal contacts between smooth muscle cells after denervation 
of the vas deferens has been proposed to increase electromechanical coupling between 
cells and result in enhanced contractile response to depolarizing agents. However, it is 
not clear whether the nexal contacts reported to exist in control vasa alone, as reported 
by Westfall et al. (1977), are an artifact since one other group has reported no nexal 
connections in the normal rat vas deferens (Paton et al., 1976) while a second group 
(Daniel et al., 1976) has shown that the technique used by Westfall's group may 
actually contribute to increased nexal structures.
The elevation in threshold potential after denervation of the vas deferens has 
also been proposed to result in enhanced response to depolarizing agents (Goto et al., 
1978). This change would result in increased ease by which agents could depolarize 
the muscle cell membrane and thus conceivably decrease the threshold concentration 
of agonists in initiating contractile activity (resultant leftward shift in the C-E curve). 
However, apart from a decrease in the threshold concentration and lowered ECM, a 
significant elevation in the maximal contractile force results after denervation. This 
phenomenon cannot be explained by the alteration in the threshold potential of the cell 
membrane.
Takenawa et al., (1983) noted an enhanced accumulation of phosphatidic acid 
in response to NE in denervated vasa as compared to control responses. The PA was 
thought to increase Ca1* mobilization and thus promote the enhanced contractile 
response to various agonists. Such a role for PA is not borne out by current
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investigations and in any case, would not explain the increased sensitivity to high K* 
and Ba3* which presumably do not occur by elevation in cellular second messengers.
A role for altered a  (-adrenoceptors in mediating the supersensitivity 
phenomenon was ruled out when no change in the number or binding affinities of the 
receptor were observed after denervation (Rice, 1983; Abel et al., 1985). Coupling of 
a ,-adrenoceptors to PIP2 hydrolysis was not found to be significantly changed after 
surgical denervation of the vas deferens (Takenawa et al., 1983; Minneman et al.,
1988) and so increased inositol phosphate production could not explain the 
supersensitivity response.
Increased sensitivity to agonists in other smooth muscle systems have 
implicated changes in protein kinase C activity as a causative factor. Unilateral 
superior cervical gangllonectomy in rabbits has produced supersensitivity to NG in 
isolated iris muscle (Akhtar and Abdel-Latif, 1986). The authors reported an increase 
of 30% in cytosolic PKC activity of denervated hides when compared to control 
tissues,
The caudal artery (Aqel et al., 1987) and thoracic aorta (Lograno et al., 1989) 
from spontaneously hypertensive rats (SHRs) has been shown to exhibit enhanced 
contractile response to NE and elevated K* relative to the response of tissues from 
Wistar-Kyoto (WKY) rats. Phorbol esters (PMA) as well as non-phorbol activators of 
PKC (mezerein) have been shown to produce greater contractile response in the 
mesenteric arteries of stroke-prone SHRs when compared with WKY vessels CRiria 
and Webb, 1987). An increase in PKC activity was proposed to mediate the enhanced
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contractile response of aortic muscle strips from SHRs since the NG response in these 
tissues was more susceptible to antagonism by H-7 (PKC inhibitor) when compared to 
WKY tissues (Shibata et al., 1990). Renal arteries from SHRs showed increases in 
cytosolic PKC activity relative to WKY controls, but such differences were not seen in 
the aortas of the same animals (Silver et al., 1992). Bazan et al. (1992) also reported 
no difference in PKC activities from aortas of SHRs and WKY rats, although the 
ability of phorbol esters to activate PKC (translocation from cytosolic to membrane 
compartment) was greater in the SHR tissue.
There is significant evidence that various pathological and adaptive conditions 
involve increased receptor or tissue sensitivity. Altered responsiveness of blood 
vessels from hypertensive animals to contractile agents has been outlined above. 
Rebound hypertension after rapid withdrawal of clonidine during antihypertensive 
therapy may be due to increased NE released from sympathetic nerves as well as 
increased receptor sensitivity of the heart and vascular muscle to circulating 
catecholamines (Hansson et a)., 1973). Normal subjects receiving guanethidine (which 
interferes with sympathetic neurotransmission) for 3 days developed supersensitivity to 
the arrhythmic effects of administered catecholamines (Fleming et al., 1973). 
Supersensitivity of cardiac muscle to circulating catecholamines has been proposed to 
maintain myocardial function of the transplanted heart in the absence of sympathetic 
innervation (Donald, 1973).
The rat vas deferens affords a smooth muscle system whereby sensitivity 
changes may be consistently induced and then studied, Application of this knowledge
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may further a better understanding of such pathophysiological alterations and 
eventually lead to better therapeutic regimes for their management.
At a more fundamental levelt such investigations would lead to a better 
understanding of smooth muscle function and plasticity. Although the primary 
initiation of contractile activity in smooth muscle appears to be via myosin light chain 
phosphorylation by a specific kinase (MLCK), many other cellular proteins (PKC, 
Caldesmon, desmin, etc.) may play a role in regulating this activity (Rasmussen et a l, 
1987). What is unclear is the extent to which these various cellular proteins may 
function in smooth muscle response. The present work attempts to define the 
contribution of PKC in mediating contractile function in the vas deferens.
Additionally, if alterations in cellular proteins are found with chronic denervation, a 
mechanism by which smooth muscle cells may enhance cell surface signaling would 
be implicated.
Aim? p f the Study
The present study was designed to evaluate the role of protein kinase C in the 
tissue supersensitivity that results from chronic denervation of the rat vas deferens. 
Experiments were done to determine a number of parameters which would be 
indicative of altered PKC function in denervated tissues when compared to the control 
vas deferens. The experimental goals of the study are as follows:
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1. to determine the functional relevance of PKC in the contractile response of the vas 
deferens by use of PKC activators as well as inhibitors. These experiments would 
provide information as to the extent to which PKC mediates normal contractile 
function in response to receptor and non-receptor agents.
2. to compare the ability of the phorbol PKC activators to produce contractile 
responses in the denervated and control vas. If enhanced response after 
denervation is due to nonspecific increases in PKC activation, these experiments 
could provide evidence for such alterations.
3. to determine the amounts of 1,2-diacyl glycerol produced in denervated and control 
vasa in response to receptor stimulation as well as to analyze the various molecular 
species of DAG produced. These experiments would indicate an increased 
activation of PKC in denervated tissues due to enhanced levels of the endogenous 
activator (DAG) formed subsequent to receptor stimulation. Changes in the 
molecular species of DAGs produced could indicate changes in a,-adrenoceptor 
coupling to different membrane phospholipases (PLC, PLD, etc.),
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4. to evaluate the binding characteristics of membrane-bound PKC from denervated 
and control vasa using the ligand [1H]phorboM2,13-dibutyrate. An increase in 
basal PKC in the membranes or enhanced affinity of the protein for activators 
following denervation would provide a mechanism by which PKC activation may 
be altered.
5. to determine the activation of PKC in denervated and control vas deferens as 
indicated by translocation of PKC from the cytosolic to the membrane fraction of 
the cell. These experiments would reveal differences in the ability of receptor 
stimulation to activate PKC in the two tissue groups. Non-receptor-mediated (K* 
and phorbol esters) translocation of PKC in the two groups would also be studied.
CHAPTER 2
Materials and Methods
Animals and Tissues 
Male CD rats (VAF) bred from Charles River CD rats in the Division of 
Laboratory Animal Resources were used in the study. On occasion additional male 
CD (VAF) rats were purchased from Charles River Labs (Wilmington, Ma.). Animals 
were housed and cared for in the animal care facility according to the guidelines of the 
American Association for Accreditation of Laboratory Animal Care. They had free 
access to food and water and were maintained on a 12 hour light/dark cycle. Rats 
weighing 300-600 g were used to obtain tissue for the experiments herein. The 
animals were euthanized by exposure to carbon dioxide gas until loss of 
consciousness, followed by cervical dislocation.
Whole vas deferens from the base of the bladder to the epididymis were 
dissected and placed in ice-cold, oxygenated, physiological salt solution (PSS). Vasa 
were carefully cleaned of the connective tissue sheath, adherent blood vessels and fat, 
while under ice-cold PSS, using fine forceps. When appropriate, tissue wet weights 
were obtained soon after tissues were cleaned and while still cold,
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Surgical Denervation Procedure 
The denervation procedure was performed essentially according to the method 
introduced by Kasuya et al. (1969). Rats were anesthetized with 60 mg/kg 
pentobarbital sodium, administered via intraperitoneal (i.p.) injection. Later the 
anesthetic was changed to a combination of ketamine (60 mg/kg) and xylazine (12 
mg/kg) also administered by the i.p. route. The ketamine/xylazine combination was 
found to produce better surgical analgesia and anesthesia as evidenced by decreased 
incision and pedal reflex. The dose of pentobarbital used was also less consistent in 
inducing rapid anesthesia or recovery of the animal after surgery. Butorphanol (2 
mg/kg, subcutaneous injection) was also given to the animals prior to surgical incision. 
This long-acting analgesic helped to speed the recovery of the animal after surgery.
Hie surgical procedure was carried out according to aseptic guidelines using 
sterile instruments and materials (Cunliffe-Beamer, 1993). The abdomen was shaved 
using animal clippers and the area cleaned with 95% ethanol followed by povidone- 
iodine solution. A 3-4 cm long, 1 cm ofF-midline, incision was made in the skin and 
abdominal muscle layer of the rat using a scalpel. The bladder as well as the seminal 
vesicle and prostate on the surgical side were exposed and immobilized with 
hemostats. The testicle on the surgical side was pulled out of the scrotal sack until the 
area where the vas deferens meets the base of the bladder was exposed (Fig. 2). The 
adherent fat in the area was removed with forceps and the vas deferens was freed from 
its mesenteric attachments.
Figure 2. View of visceral organs during denervation surgery. Dashed lines indicate 
nerves entering the vas deferens and the arrow points to the area of phenol application.
Under a magnifying lens up to 3 individual nerve fibers could be seen entering the vas 
deferens via the connective tissue sheath, while, a fourth usually entered along with 
the deferential artery. Using fine forceps the connective tissue sheath around the 
tissue, from the base of the bladder to the junction of the deferential artery and vas 
deferens was carefully removed with minimal bleeding.
To destroy the nerves which entered with the artery, as well any that had been 
missed with the forceps, 3 to 4 drops of 5% phenol (wt./vol in water) were applied to 
the area. Subsequently, the abdominal musculature was closed using silk surgical 
suture and the skin incision was secured with metal wound clips. The animal was 
then wrapped in paper and placed in the cage for recovery. The right or left vas 
deferens was randomly denervated in each animal and the contralateral tissue was left
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intact as the control. The rats were allowed to recover usually for 6 to 8 days before 
the denervated and control tissues were dissected out.
Contractile Studies of the Vas deferens
Tissue Preparation and Equilibration
Adult, male CD rats (300-600 g) were used as the source of fresh vas deferens 
in these studies. The animals were anesthetized with carbon dioxide and killed by 
cervical dislocation. Both vasa deferentia were rapidly removed and placed in ice- 
cold, oxygenated, physiological salt solution (PSS). The tissues were cleaned of 
blood vessels and adhering connective tissue (under cold buffer) using fine forceps.
The vasa were then placed in individual jacketed organ baths containing PSS (see 
Appendix A for preparation scheme) of the following composition (mM); NaCl (113); 
KC1 (4.7); CaCIj (2.5); MgS04 (0.57); NaHCO, (25); NaHP04 (1.01) and dextrose 
(5.55). The buffer was continuously aerated with a mixture of 95% 0 2 and 5% C 02 
and maintained at 37°C throughout the experiment.
Measurement of Contractile Response
Vasa deferentia were suspended vertically in 25 ml organ baths with one end 
attached to Grass force-displacement transducers (FT03C) and the other end to the 
bottom of the organ bath via cotton thread. The tissues were maintained at 250-300 
mg resting tension, and isometric contractile responses were recorded by a Grass
27
Model 7D polygraph (Quincy, MA.). Following a 60-90 mln equilibration period, all 
tissues were exposed to 10 pM norepinephrine (NE) challenge as this allowed 
subsequent responses of the tissue to be more consistent. An additional washout and 
re-equilibration period (45 min) preceded further exposure to contractile agents. The 
buffer in the organ baths was replaced with pre-waimed PSS every 15-20 min during 
the course of the experiments. Contractile agents and antagonists were applied in 10- 
25 pi volumes of solvent using Eppendorf digital pipettes. Cumulative concentration- 
effect curves (C-E curves, van Rossum, 1963) to contractile agents were constructed 
by their addition to each organ bath in approximately 0.5 log unit increments to the 
final concentrations indicated.
Assessment of the Denervation Procedure
The success of the denervation procedure was determined in vitro by the use of 
tyramine which is able to enter intact adrenergic nerve terminals and elicit a 
contractile response by causing the release of endogenous NE (Birmingham, 1970). In 
the organ baths denervated and control vasa were exposed to 100 pM tyramine and 
the contractile responses recorded. Only tissues producing 10% or less of the control 
tyramine response were considered sufficiently denervated to be used in the study.
PKC_and_NonnaLContractile_EunctiQn
The role of PKC in the contractile activity of normal rat vas deferens was 
studied using PKC activators and inhibitors to assess the extent to which these agents
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would influence the contractile activity of the tissue. In most experiments exposure to 
phorbol-12,13*diacetate (PDA), phorbol-12,13*dibutyrate (PDB), mezerein or 4a- 
phorbol followed a 1 min pre-exposure of rat vas deferens to PSS containing 20 mM 
K \ In each case that buffer concentrations of K* were increased, equivalent Na* was 
removed to maintain osmolarity (see Appendix B for preparation).
Tissues were incubated with 30 nM nifedipine for 10 min or 30 jiM woH-7 for 
20 min prior to agonist exposure. Paired vas deferens exposed to vehicle (ethanol or 
distilled water, respectively) served as control for these experiments. Modulation of 
the NE response by PDA was studied by adding 2 pM of the agent to the tissue baths 
10 min prior to the construction of concentration-effect curves for NE. Control NE 
responses were elicited in the presence of the vehicle (0.1% DMSO, v/v).
PKC and DenervatioiLSuDersensitivitv
Contractile response to NE (single concentration or cumulative C-E curves, 10 
nM-30 pM) were produced in denervated and control vasa to characterize the 
supersensitivity that develops after chronic denervation of the tissue. Cumulative C-E 
curves to neuroldnln A (NKA, 1 nM-3 pM) were also produced in pairs of control 
and denervated tissues. The role of voltage-dependent calcium channels on the NE 
response in denervated and control tissues was determined after treatment of both 
groups of vasa with 100 nM nifedipine for 10 min. This concentration of nifedipine 
was used since it was found to significantly antagonize the NE response without 
abolishing it. The effect of direct PKC activation in denervated and control tissues
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was determined by producing contractile responses (cumulative C-E curves) to PDA in 
both groups in PSS with 20 mM K* and 10 jiM phentolamine. Phentolamine was 
used to antagonize the contractile response that could result from the release of 
endogenous NE in adrenergic nerve terminals, especially in the control tissues. The 
concentration of phentolamine used was sufficient to completely antagonize the 
response to 10 pM NE applied exogenously.
Diacvl glycerol Production in the Rat Vas Deferens
Tissue Preparation
Whole vas deferens (denervated and control) were dissected from freshly kilted 
rats and placed in cold, oxygenated PSS and cleaned of adhering connective tissue, 
blood vessels and fat. Tissues were allowed to equilibrate under physiological 
conditions in organ baths for about 1 hour before exposure to a 10 NE challenge. 
This was followed by a 45 min washout and equilibration period before subsequent 
exposure to 100 liM NE for 0, 30, 60, 120, 300 and 600 s. At this time the 
stimulation was terminated by quickly placing the tissue in liquid nitrogen.
Sample Preparation
Immediately following the freezing of the tissue with liquid nitrogen, it was 
placed in a ground glass homogenizer containing 3 ml chloroform/methanol (2:1 
vol/vol) which had been cooled to -10°C, The tissue was homogenized completely
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with rapid strokes and then the homogenate was pipetted out and placed in 20 ml 
scintillation vials. The homogenizer was rinsed with 1 ml of the chloroform/methanol 
mixture which was also pipetted out and added to the scintillation vial. Vials were 
tightly capped and stored at -20°C until extraction and analysis (within two weeks).
Neutral Lipid Extraction
The lipids in the sample were extracted according to the Bligh and Dyer (1959) 
technique. Into each scintillation vial 2 ml of chloroform/methanol (2:l,v/v) followed 
by 4 ml methanol and 2.5 ml water were added. The vials were vottexed and 
methanol was added drop-wise until the cloudy suspension became clear. Three ml 
chloroform and 3 ml H20  were added, the vials vortexed and centrifuged at 800 X g 
for about 1 min. Separation of the mixture into an aqueous (above) and organic 
(below) phase was achieved by centrifugation. The lower phase was carefully pipetted 
into 10 ml tubes and the upper phase was re-extracted with 3 ml of chloroform which 
was also pipetted out after further centrifugation. The lipids of interest were 
extracted into the chloroform layer which was then dried under a stream of nitrogen 
with repeated rinsing of the tubes with chloroform to concentrate the lipids at the 
bottom of the tube. Once all the solvent was removed 200 pi of chloroform was 
added to each sample. Tubes were tightly capped and stored at -20°C or samples 
were immediately spotted onto thin layer chromatography (TLC) plates.
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Thin Laver Chromatography
Silica gel O plates (20 X 20 cm, Analtech Inc., Newark, DE.) were activated at 
70°C for at least an hour before use. The plates were channelled with lanes of 1 cm 
width and only the middle 18 lanes were used. Chromatography tanks were prepared 
by equilibrating them with 100 ml of hexane/diethyl ether/acetic acid (20:80:1, v/v/v) 
for about 1 hour before use. Known amounts of cholesterol and 1,2-dipaImitoyI 
glycerol standards (0.4 - 10 pg), dissolved in chloroform, were applied to each plate.
Five and 50 pi of each sample in chloroform were applied to the TLC plate 
using disposable glass mlcrocapillaiy plpets (Fisherbrarufi, lusher Scientific,
Pittsburgh, PA.). The plates were placed in the developing tank until the solvent front 
traveled about 14 cm (in about 30-40 min). Plates were air dried and then sprayed 
with 10% copper sulfate in 10% phosphoric acid and allowed to dry further. Lipids 
were visualized by charring the plates over a hot plate (Thermolyne, Dubuque, Iowa) 
which had been warmed to setting 6 for at least 10 min prior to use.
Analvsis_and_QuantificationoLLipids.
Charred TLC plates were scanned by a Howtek 3+ Digital scanner and the 
image was recorded and analyzed by using Bio-Image (Millipore, Milford, MA.) 
image analysis system on a SUN workstation. Density profiles for each spot on the 
plate were produced, from which the integrated optical density was obtained. The 
amount of tissue lipids (cholesterol and DAO) were determined from the standard 
curve obtained by plotting the mass of cholesterol or dipalmitin (0.4-10pg) against the
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integrated optical density obtained for these standards. GraphPad's InPIot (San Diego, 
CA.) curve fitting program was used to produce the standard curves from which the 
mass of the sample DAO and cholesterol could be determined. The amount of 
diacylglycerol in each tissue sample was then corrected for recovery rate of extraction 
and variation in tissue weight simply by dividing the mass of DAG by the cholesterol 
mass in the same sample. This could be done since cholesterol mass remains quite 
stable and is proportional to the number of cells in the tissue, and thus the tissue mass 
(Datta, 1987). The final data were expressed as ng DAG/pg cholesterol for each 
tissue sample.
Molecular species of DAG_bv_HPLC
Sample Preparation. The molecular species of DAG that resulted from receptor 
activation in denervated and control tissues were resolved by reverse-phase HPLC. 
Three previously extracted neutral lipids samples from denervated and control vasa, 
stimulated with 100 pM NG for 0 ,60 and 300 s, were pooled and then dried under a 
stream of nitrogen. Hie lipids were dissolved in 300 pi of chloroform, spotted on 
TLC plates and resolved in the hexane/diethyl ether/acetic acid system along with the 
appropriate standards.
The DAG spots on the plates were visualized by spraying the plates with 0.5% 
dichloroflouresceln (in ethanol) with the stain being enhanced by holding the plate in a 
tank of ammonia. The silica gel containing the DAG spots was scrapped off the plate
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and placed in 10 ml tubes containing 2 ml ethanol (95%). Two ml of hexane and 2 
ml of water were added to the tubes which were vortexed and then centrifuged at 800 
X g for 30 s. The upper hexane layer was carefully pipetted out and placed in a 
second 10 ml tube. The lipid mixture contained in the silica gel was re-extracted by 
repeating the same process twice with 2 ml of hexane. The hexane containing the 
sample lipids was dried off under nitrogen with repeated rinsing of the walls of each 
tube to isolate the lipids at the bottom.
Benzovlation Procedure. Sample DAGs were converted to the benzoyl 
derivatives before separation by HPLC. To each tube 100 pi of benzene, 20 pi of 
benzoic anhydride (50 mg/ml, in benzene) and 10 pi of dimethyl aminopyridine (40 
mg/ml, in benzene) were added. The tubes were shaken, flushed with nitrogen, tightly 
capped and allowed to sit at room temperature for about 24 hours. At that time 200 
pi of ammonium hydroxide was added to each tube to stop the reaction. Ten minutes 
later 2.5 ml acetonitrile, 0.5 ml water and 3 ml hexane were added to the tubes 
followed by vortexing and centrifugation to separate the organic and aqueous layers. 
The upper hexane layer was pipetted into a second tube and the contents of the first 
tube were re-extracted twice with 3 ml of hexane. The tubes were dried under 
nitrogen stream with frequent rinsing of the walls, and the lipid at the bottom was 
dissolved in 100 pi of acetonitrile/isopropanol (70:30, v/v).
Reverse-phase HPLC. The various species of diacylglycerol were resolved by 
reverse-phase HPLC using an Ultrasphere-ODS column (Altex, Berkeley, CA., 4.5 X 
250 mm) and mobile phase of ac et oni t ri 1 e/isopropanol (70:30, v/v) at 35°C. The 
mobile phase flow rate of 1.4 ml/min was generated by a Peridn-Elmer Series 410 LC 
pump and DAO derivatives detected by a Perkin-Elmer LC-95 UV/visible 
spectrophotometer with absorbance at 230 nm. For data collection the detector was 
interfaced to Maxima 820 chromatography workstation (Dynamic Solutions, Millipore, 
Milford, MA.) by which the resulting chromatograms were stored for later analysis. 
Molecular species of DAO in the sample were compared to known species that had 
been previously derivatized to the benzoyl form. The standard mix of DAO 
derivatives that were resolved by HPLC contained 1,2-dimyristoyl glycerol (14:0- 
14:0), 1,2-dipentanodecyl glycerol (15:0-15:0), 1,2-dioleoyl glycerol (18:1-18:1), 1- 
paImitoyl-2-oleoyl glycerol( 16:0-18:1), 1,2-dipalmitoyl glycerol (16:0-16:0), 1-stearoyl- 
2-oleoyl glycerol (18:0-18:1), 1,2-dtstearoyl glycerol (18:0-18:0) and l-steatoyl-2- 
arachidonyl glycerol (18:0-20:4).
DAO Mass bv High-Pressure Liquid Chromatography
Sample Preparation. Tissues and samples were prepared essentially as 
indicated for determining DAO mass by thin layer chromatography with minor 
changes. Control vasa were exposed to 10 pM NE for 0-10 min under physiological 
conditions and then rapidly frozen in liquid nitrogen. Whole tissues were then placed
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in scintillation vials containing 3 ml of chloroform/methanol (2:1 v/v) while stilt 
frozen and stored at -20°C until the extraction procedure (usually 1 week later). fH] 
cholesterol (200,000 dpm) and [3H] dipalmitin (10,133 dpm) were added to each 
scintillation vial before the neutral lipid extraction procedure outlined above (Bligh 
and Dyer, 1959), was undertaken. The radiolabelled lipids were eventually used to 
estimate the recovery of sample lipids from the vials.
Column Fractionation. The extracted lipids were dried under nitrogen and 
dissolved in 500 pi of hexane/methyl-tert-butyl ether (96:4, v/v) in preparation for 
column fractionation, A Fisher Prep-Sep Si (300 mg) column was conditioned by 
rinsing with 10 ml isopropanol, followed by 2 X 5 ml methyl-tert-butyl ether (MTBE) 
and then 2 X 10 ml of hexane. All of the extracted lipid samples were applied to the 
column and the tubes containing the lipid samples were rinsed with two further 
aliquots (500 |il) of hexane/MTBE which were also applied to the column. Each 500 
pi aliquot of sample was allowed to enter the column and then rinsed with 2 X 2 ml 
of hexane/MTBE (96:4) to elute triglycerides and cholesterol esters in the sample.
The columns were then rinsed with 2 X 1.5 ml of hexane/MTBE/acetic acid 
(100:2:0.2, v/v/v) to remove fatty acids. Cholesterol, diacyl- and monoacylglycetols 
(MAG) were eluted from the column by 2 X 3 ml of MTBE/acetic acid (100:0.2) and 
collected in 10 ml tubes. The solvent was evaporated under nitrogen with repeated 
washings using chloroform to isolate the lipid sample at the bottom of the tubes.
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Lipid Separation and Quantification by HPLC. The isolated cholesterol, DAG 
and MAG were benzoylated and collected just as described above for DAG from the 
TLC extract. The benzoylated derivatives were then dissolved in 100 ill of 3.2% 
MTBE in cyclopentane (v/v). The lipid components were then resolved by normal- 
phase HPLC using an Ultrasphere SI column (Altex, Berkeley, CA.) in a mobile phase 
of 3.2% MTBE in cyclopentane (v/v) at a flow rate of 1.0 ml/min and 35CC.
The lipids that eluted from the column were detected by a Perkin-Elmer LC-95 
UV/visible spectrophotometer with absorbance set at 230 nm. The resulting 
chromatograms were stored onto the hard disk drive of a NEC A PC IV personal 
computer by the use a Maxima 820 chromatography workstation. The cholesterol 
fraction that eluted from the column was collected in 10 ml tubes while the DAG that 
eluted was collected in 20 ml scintillation vials.
The cholesterol fraction was dried under nitrogen and dissolved in 400 pi 
acetonitrile/isopropanol (63:37, v/v). About 20 pi of this sample was then resolved by 
reverse-phase HPLC using an Ultrasphere-ODS column, acetonitrile/isopropanol 
(63:37) mobile phase and 1.4 ml/min flow rate. The chromatograms were stored on 
disk for further analysis and the cholesterol fraction eluting from the column was 
collected in a second set of scintillation vials.
Scintillation vials containing the earlier collected DAG and the later cholesterol 
were dried under nitrogen and the lipids were dissolved in 200 pi methanol. Ten ml 
of scintillation cocktail were added to the vials before radioactivity determination in a 
liquid scintillation counter (LS 6800, Beckman Instruments, Irvine CA,). The counts
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in each sample were a measure of the recovery rate of cholesterol and DAG from each 
sample. The area under the peaks corresponding to cholesterol, DAG and MAG were 
calculated using Maxima's peak integrating function. Using the peak area and 
correcting for the recovery of lipid in each sample, the amount of cholesterol, DAG 
and MAG in each sample was determined in volt*second. Using the molar 
absorptivity of 13,200/M*cm for the benzoyl ester (Wame and Robinson, 1991) and 
conversion factor 802140 pV*s/nmol for normal-phase (DAG and MAG) and 572957 
pV* s/nmol for reverse-phase chromatograms (cholesterol), the lipid mass was 
determined in nmoles. The conversion factors were determined by chromatography of 
known amounts of 1,2-[3H]dipalmitoylglycerobenzoate and pHJchoIesteryl benzoate 
and lipid mass verified by scintillation counting. The amount of DAG and MAG was 
then normalized to the amount of cholesterol in each sample to account for differing 
mass of tissue, with the final data being represented as nmol DAG or MAG/pmol of 
cholesterol.
Binding Studies in the Rat Vas Deferens
Xissuc-and_SampiC-Prcparation
Freshly dissected vasa from animals seven days after surgery were placed in 
ice-cold, oxygenated PSS and cleaned of connective tissue and attached blood vessels. 
Denervated and control vas deferens were mounted in isolated organ baths, bathed in 
oxygenated PSS and under 250-300 mg of tension. After about an hour of
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equilibration, each tissue was exposed to 100 pM tyramine to verify successful 
denervation of the experimental tissues. Denervated vasa that did not respond to 
tyramine were exposed to 10 pM NG and then all tissues were washed with fresh PSS 
and incubated for a further 45 min.
Each vasa was placed in a ground glass homogenizer and manually 
homogenized in 2.5 ml of ice-cold 25 mM MOPS buffer containing 250 mM sucrose, 
2,5 mM EDTA, 2 mM EGTA, 10 mM fl-mercaptoethanol, 5 mM dithiothreitol and 10 
pg/ml leupeptin. The homogenate was transferred to 15 ml polycarbonate tubes and 
centrifuged in a Beckman J2-21M centrifuge (Beckman Instruments, Irvine, CA) at 
50,000 X g for 30 min. The resulting supernatant was discarded and the pellet 
resuspended in 5 ml of MOPS buffer (containing 5 mM CaCl2 and 8 mM MgCl2) 
using a Kontes microtip sonicator/cell disrupter (Electro-Mech Instruments, Perkasie, 
PA,), The suspension was centrifuged a second time at 50,000 X g for 30 min and the 
supernatant was discarded. The pellet was resuspended in 3 ml of 25 mM MOPS 
buffer (5 mM CaQj, 8 mM MgG2, pH 7.4 at 37°C) using a sonicator and then either 
kept on ice until the binding assay was performed or stored at -20°C for up to 2 weeks 
before assay.
Binding Assay Procedure
Protein Assay. Aliquots (100 pi) of the membrane samples in MOPS buffer 
were assayed for protein content using a modified procedure of the method introduced
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by Lowiy et al. (1951, see Appendix C) and using bovine serum albumin as the 
protein standard.
Saturation Binding Assay. The binding characteristics of membrane-bound 
protein kinase C from denervated and control samples were compared using the 
pHJphorbol dibutyrate binding assay. The assay was done in 1.5 ml microcentrifuge 
tubes at 37°C in a shaking incubator/water bath (Precision Instruments, Chicago, IL.). 
Each microfuge tube contained 0.1 - 80 nM of pH] phorbol dibutyrate ([3H]PDB, 
diluted from the stock in MOPS buffer) and 50 - 150 pg of protein sample (in MOPS) 
in 250 pi total volume. On occasion 10 pM of mezerein (a non-phorbol PKC 
activator) was present in each tube to account for non-specific binding of the ligand. 
The microfuge tubes were incubated in the water bath for 20 min at 37°C and pH 7.4, 
with constant agitation.
At the end of the incubation period, the tubes were quickly removed from the 
incubator and placed in a microcentrifuge. The tubes were centrifuged at 16,800 X g 
for 15 min to separate free and bound ligand. An aliquot of the supernatant (100 pi) 
was pipetted Into 20 ml scintillation vials and counted to determine the free 
concentration of the pH]PDB. The rest of the supernatant was pipetted out and 
discarded into appropriate storage containers. The tip of each microfuge tube 
containing the membrane pellet was cut into a 20 ml scintillation vial using a sharp 
blade. The pellet was treated with 200 pi of 0.5 N sodium hydroxide in 0,5% sodium 
lauryl sulfate for about 30 min to digest the pellet protein, Bio-Safe n  scintillation
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cocktail (10 ml) was added to the vials which were then allowed to sit overnight 
before the radioactivity was determined. Vials were counted for 10 min each in a 
Beckman LS 9800 scintillation counter (Beckman Instruments, Irvine, CA.) at 35-41% 
efficiency.
Competitive Binding Assay. The binding characteristics of unlabelled PDA, 
PDB, mezerein and 4cc-phorbol in control vasa were determined by competitive 
binding of these agents with pHJPDB. As with the procedure outlined above, the 
assay was performed in 1.5 ml mlcTofuge tubes in 250 pi MOPS buffer with 50-150 
pg protein and 5-10 nM of pHJPDB, Various concentrations of PDA (1-10000 nM), 
PDB (0.1-3000 nM), mezerein (0.1-3000 nM) and 4a-phorbol (0.1-300 pM) were 
added to each tube. Tubes were incubated for 20 min at 37°C and pH 7.4 in a shaking 
incubator. Bound and free ligand were separated by centrifugation as indicated above 
and the radioactivity was determined by liquid scintillation counting.
Protein Kinase C Activity in Rat Vas Deferens
Tissue and Sample Preparation
Denervated and control vasa were prepared and incubated in PSS as outlined 
previously. To determine differences in the ability of a-adrenoceptor stimulation to 
activate PKC, each tissue was exposed to 100 pM NE. The tissues were stimulated 
with NE for 0, 1 ,2 ,5 ,  and 20 min at which time they were quickly blotted on tissue
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paper and manually homogenized in a ground glass apparatus containing ice-cold 
buffer. The volume of homogenizing buffer used for each tissue was 50 volumes of 
the tissue wet weight, and consisted of 25 mM MOPS (pH 7.4 at 25°C) 250 mM 
sucrose, 2.5 mM EDTA, 2 mM EGTA, 10 mM P-mercaptoethanol, 5 mM DTT, 1 
mM phenylmethylsulfonyl fluoride and 5 pg/ml leupeptin.
The homogenate was centrifuged at 50,000 X g  for 30 min at 4CC and the 
supernatant (cytosolic fraction) was pipetted out and stored in capped 5 ml 
polypropylene tubes at -20°C. The pellet was resuspended in 4 ml of homogenizing 
buffer using a Kontes micro-ultrasonic cell disrupter (Electro-Mech Instrument Co., 
Perkasie, PA). The suspension was also stored frozen until the assay procedure (2 
weeks later). On the day of the assay, the samples were thawed at room temperature 
and kept on ice.
The pellet suspension was treated with Triton X-100 (0.3% final concentration) 
for about an hour, while on Ice, with intermittent mixing using a sonlcator. The 
mixture was then centrifuged at 50,000 X g and 4°C for 30 min. The supernatant 
containing the solubilized membrane proteins was saved as the particulate fraction and 
kept on ice. The particulate and cytosolic fractions (100 pi aliquots) were then 
assayed for protein content using the Bio-Rad protein assay reagent (Bio-Rad 
Laboratories, Hercules, CA.) with bovine-Y-globulin as the protein standard (Appendix 
D). Hie samples were all diluted with the homogenizing MOPS buffer to a final 
protein concentration of 40 pg/ml before assaying for PKC activity.
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Protein.Kinase_CActivitv_Assav 
The paniculate and cytosolic cell fractions were assayed for PKC activity using 
a commercially available kit from Amersham. The assay detects the ability of sample 
PKC to transfer the labelled phosphate group from [y-3IP!ATP onto a threonine 
residue on the peptide substrate in the presence of optimal concentrations of calcium, 
phosphatidylserine and phorbol myristate acetate (PMA). The peptide substrate is 
derived from the epidermal growth factor (EGF) receptor which has been shown to be 
directly phosphorylated by PKC during cell activation with EGF (Heasley et al., 1989). 
Twenty five pi of each diluted sample (1 pg protein content) was incubated with [y- 
” P]ATP (22,000 dpm), 75 pM substrate peptide, lmM calcium acetate, 3.75 mM 
magnesium acetate, 2 pg/ml phorbol 12-myristate 13-acetate (PKC activator) and L-o- 
phosphatidyl-L-serine in 75 pi total volume. The reaction tubes were incubated at 
25°C for 15 min and the reaction stopped with the addition of 100 pi dilute acid. An 
aliquot from each tube (125 pi) was spotted onto a 4 cm1 piece of peptide-binding 
paper which was then rinsed twice in 5% acetic acid (10 ml/paper) for 10 min. The 
papers were then placed in 20 ml scintillation vials along with 10 ml Bio-Safe n  
cocktail. The vials were capped and counted without delay for 32P for 10 min each on 
a Beckman LS 9800 counter (Irvine, CA.). Blank runs with no protein sample were 
performed simultaneously to account for nonspecific binding of radioactivity to the 
binding papers. Eight particulate and cytosolic samples from the two groups were 
randomly chosen and assayed for PKC in the absence of Ca2\  PMA and PS. This was 
to determine nonspecific kinase activity in the samples.
Calculations and Statistics
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Contractl!e_Studies
Data are usually represented by the mean (± S.E.M.) response as a percent of 
the paired, control response, for 3-7 animals. This method of data representation 
decreased the variation between animals and allowed for more rigorous comparisons. 
The one- and two-way analysis of variance with least significant difference (LSD) 
were used to compare mean responses. Bonferroni's multiple comparison test was 
applied to analyses that resulted in nonsignificant F-ratios. The Students t-test was 
only used when the variation of the means were equivalent for the two groups being 
compared. Levels of P < 0.05 were accepted as indicative of significant differences 
between the groups being compared. Statistical analyses were done on an IBM- 
compatible personal computer using the SPSS/PC* Studentware (SPSS Inc., Chicago,
IL .) or InStat (San Diego, CA.) software packages.
Diacvlglvcerol Studies
The mass of DAG and MAG were expressed in terms of the cholesterol content 
of each sample to account for differences in lipid recovery after the extraction 
procedure as well as to normalize for the differing mass of the tissues. The mean ± 
S.E.M. or S.D. of these values were used to represent the data. Data were not reduced 
to percent values in order to allow for comparisons with further experiments. One­
way analysis of variance (InStat software, San Diego, CA.) was used to compare
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means and probability values less than 0.05 were accepted as indicating statistical 
difference.
PHIPDB Binding Studies
Data obtained from the radioligand binding assays were converted from counts 
per minute to picomoles of binding per milligram of protein by using a spreadsheet 
program (SwiftCalc, Northbrook, IL.) on a personal computer. In the saturation 
binding assay these values were then used to determine the binding maximum (B^,,) 
and dissociation constant (K4) of [3H]PDB in the protein samples obtained from 
denervated and control vasa. Using the non-linear regression analysis available on 
GraphPad InPlot software (San Diego, CA.), the data were fit to the equation:
Total Binding » | ^ J L?gan^ , + N [Ligand],
Kd+ [Ligand]
where N» [Ligand] represents the nonspecific binding of the ligand. The B ^, 
represents the maximum number of binding sites in pmoles per mg protein whereas 
the Kd is the dissociation constant of [3H]PDB for the binding site in nanomolar.
In the competitive binding studies the data were reduced to percent of maximal 
binding for each of the unlabelled ligands. These values were fit to the competitive 
binding equation for one or two sites using GraphPad's curve fitting program. The Kd 
for the competing ligands were calculated by converting the ICjo using the Cheng and 
Pnisoff (1973) factor.
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K = IC«
1 j + [Ligand] ’
Kd
where Kj is the dissociation constant of the competing unlabelled compound, and Kd is 
that of [1H]PDB and [Ligand] is the concentration of the pH]PDB. This analysis was 
also performed using GraphPad InPlot. The mean values of B ^, and Kd (± S.E.M.) 
obtained for the denervated and control samples were compared by paired Student's t- 
test, with P < 0.05 as indication of statistical difference.
PKC Activity in Vas Deferens
The efficiency of 3JP counting was assumed to be 100% and counts per minute 
were converted to nmoles of phosphate transferred to the peptide substrate per min per 
mg of sample protein (nmol/min/mg), according to instructions available with the kit. 
These values from each of the 4 tissues (animals) in each treatment group were 
averaged (mean ± S.G.M.). Using one-way analysis of variance changes in PKC 
activity in particulate and cytosolic fractions after agonist stimulation were compared 
to basal activities in resting tissues. Changes in corresponding denervated and control 
tissue PKC activities after agonist stimulation were also compared by analysis of 
variance. Probability values less than 0.05 were accepted as indicating significant 
differences between the means under comparison.
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Materials and chemicals
Contractile Studies
(-)-Norepinephrine bitartrate, l-oleoyl-2-acetyl-sn-glycerol (OAO), PDA, PDB, 
mezerein, 4 a-phorbol, nifedipine, and l-(5-isoquinolinylsulfonyl)-3-methylpiperazine 
(isoH-7) were obtained from Sigma Chemical Co, (St. Louis, MO.). Neurokinin A 
(NKA) was purchased from Bachem California, Inc. (Torrance, CA.) and phentolamine 
was a kind gift from Ciba-Geigy (Summit, NJ,). PDA, PDB, mezerein and 4a- 
phorbol were dissolved in DMSO and chloroform was the solvent for OAG.
Nifedipine was initially dissolved in ethanol and dilutions were made In distilled 
water. Final concentration of solvents in the organ baths did not exceed 0,1% (v/v). 
All other agents were dissolved in distilled water or PSS before addition to organ 
baths, Reagents and chemicals were obtained from Fisher Scientific (Pittsburgh,
PA.).
DAG Studies
Methanol, chloroform, hexane, methyl-tert-butyl ether and cyclopentane were of 
HPLC grade and purchased from Burdick and Jackson (Muskegon, MI.). Benzene, 
benzoic anhydride, benzoyl chloride and pyridine were from Aldrich Chemical Co. 
(Milwaukee, WI.). (1^-JH(N)) Cholesterol (62,0 Ci/mmol) was from New England 
Nuclear (Boston MA.) while the pH] dihexadecanoyl-sn-glycerol (fH] dipalmitin) was 
prepared from L-a-dipalmitoyl [2-9,10-3H(N)]phosphatidylcholine (50.0 Ci/mmol,
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NEN) by phospholipase C (Bacillus cereus, Type Xmt Sigma Chem. Co., St. Louis, 
MO.) hydrolysis (Wame and Robinson, 1991). 1,2-diecylglycerol standards were 
purchased from Sigma or prepared by phospholipase C hydrolysis of the appropriate 
phosphatidylcholine species (Sigma Chem. Co.) as described above.
Binding Studies
3-(N-morpholino) propane sulfonic acid (MOPS), EDTA, EGTA, leupeptin, 0- 
mercaptoethanol and dithiothreitol were obtained from Sigma Chem. Co. (St. Louis, 
MO.). [20-3H(N)l Phorbol-12,13-dibutyrate (18-20 Ci/mmol) was purchased from 
New England Nuclear (Boston, MA.). Bio-Safe II scintillation cocktail was from 
Research Products International (Mount Prospect, IL.) and all other chemicals and 
reagents were from Fisher Scientific.
PKC_Activitv_Studies
The protein ldnase C kit and [y-3JP]ATP (3000 Ci/mmol) were purchased from 
Amersham Life Sciences (Arlington Heights, IL.) whereas the Bio-Rad protein assay 
was from Bio-Rad Labs (Hercules, CA.). The bovine-Y-globulin, EDTA, EGTA, 
phenylmethyl5ulfonyl fluoride, DTT and leupeptin were from Sigma Chem. Co. (St. 
Louis, MO.). All other chemicals and reagents were from Fisher Scientific.
CHAPTER 3
Results
Contractile Studies in the Vas Deferens
Normal Contractile function and PKC.
Exposure of the rat vas deferens to 10 pM NE caused a rapid increase in 
contractile force that reached a maximum within 25-30 seconds and then decayed to a 
steady tonic phase within 2-3 min (Fig. 3A). Neurokinin A (NKA, 2 pM, not shown) 
and K* (60 mM, Fig. 7) challenges also produced similar profiles.
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Figure 3 (A) Typical isometric response to 10 pM NE in the rat vas deferens. (B) 
Response to 20 mM K*-PSS followed by 2 pM PDA in the same tissue. (C) Response 
to 2 pM 4 a-phorbol in 20 mM K*-PSS. Resting tension on all tissues at the beginning 
of the trace is 250 mg. *W' indicates tissue rinsed with fresh PSS.
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Exposure of vasa deferentia to PDA or PDB alone produced, at best, a small 
transient contractile response (less than 10% of the maximal NE response). However 
In the presence of PSS containing 20 mM K \ 2 pM PDA produced a prompt phasic 
response that was 87 ±0.1% (n-4) of the 10 pM NE response. Contractile force was 
maximal within 2 min (Fig. 3B) and then decayed to a sustained tonic phase (later 
tonic response not shown). By varying the Kf concentration of the PSS from 10-40 
mM maximal PDA response was found to occur in PSS containing 20 mM K \
Phorbol-12,13-dibutyrate (2 pM) also elicited a contractile response that was 50 ± 2.8 
% of the maximal NE response (n*<4; not shown) whereas the inactive, 4a-phorbol (2 
pM), was unable to elicit any contractile response (Fig. 3Q. The responses to PDA 
(in the presence of 2 0  mM K*) were concentration-dependent with an EC*, of 190 ±
26 nM (n-4, Fig. 4).
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Figure 4. Cumulative concentration-effect curve for PDA in 20 mM K*-PSS. 
Each point represents the mean response (± S.E.M.) of four animals.
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Contractile responses to PDA and PDB were immediately reversed by rinsing 
tissues with normal PSS and were attenuated by 20 min pretreatment with 30 pM 
froH-7, a PKC inhibitor. Prior treatment of vas deferens with 30 nM nifedipine, a 
dihydropyridine calcium channel blocker, resulted in greater than 80% decrease in the 
PDA contractile response (P < 0.05, Table 1). Neither chronic surgical denervation of 
the vas deferens (Table 1) nor 10 pM phentolamine pretreatment (not shown) had an 
effect on the maximal PDA response obtained in the 20 mM K*-containing PSS. The 
DAG analog, OAG (10 pg/ml), did not produce a significant contraction (in normal or 
20 mM K*-PSS) when compared to paired tissue exposed to the vehicle (chloroform, 
not shown).
The contractile responses of the vas deferens to NE and NKA were non- 
compethlvely inhibited by pretreating vas deferens with 30 pM froH-7 for 20 min. 
Maximal responses to NE and NKA were reduced to 42 and 30% of control (P < 
0.005), respectively (Figs. 5 and 6 ). IsoW-1 also depressed maximal phasic responses 
to 60 mM K* and 2 pM PDA (65 and 49% of control, respectively, P < 0.05). IsoH-1 
treatment of rat vas deferens resulted in a marked loss in the sustained (tonic) response 
to K* (Fig. 7) and PDA (not shown).
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Table 1
The effect of various treatments on the 2 jiM PDA-induced (in 20 mM K*-P5S) 
contractile response in the rat vas deferens.
One vas deferens was used as the control tissue while the paired tissue was either 
chronically denervated, treated with 30 pM fcoH-7 (20 min) or treated with 30 nM 
nifedipine (10 min) prior to eliciting the PDA response. Data are represented by the 
mean (± S.E.M.) response of 4-6 animals, expressed as a percent of the control 
response.
Conditions n Contractile response to PDA
in 20 mM K*-containing PSS 
(% of the control response)
Paired control 4 1 0 0
7-day denervated 6 128.9 ± 17.8
After isoH-7 4 49.2 ± 6.0 1
After nifedipine 4 15.9 ± 3.3 b
•* Significantly different from control, P < 0.05 and P < 0.005, respectively.
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Figure 5. Cumulative C-E curve to NE in control and 30 liM isoU-7 treated rat 
vas deferens. Data are the mean (± S.E.M.) response of three animals.
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Figure ti. Cumulative C-E curve for NKA in control and 30 nM isoH-7 treated 
vas deferens. Data are the mean (± S.E.M.) response from four animals.
53
a
o60mM K
2 min
t .
60mM K*
Figure 7. Representative tracings of the contractile response to 60 mM K+ in 
control (A) and 30 pM isoH*7 treated (B) vas deferens. Resting tension on the 
tissues prior to stimulation was 250 mg.
54
Vas deferens pretreated for 10 min with 2 pM PDA in normal PSS showed no 
significant change in the onset of response or the EC*, of the subsequent NE 
concentration-curve effect (Fig, 8 ). The maximal response to NE in the presence of 
PDA was greater than with NE alone in every case but narrowly failed to achieve 
statistical significance by two-way analysis of variance (P < 0.07) and Bonferroni's 
test.
200
[Norepinephrine] (M)
Figure 8 . NE response after 10 min PDA (2 pM; • )  or vehicle (DMSO; O) 
pietreatment of paired vas deferens. Responses are represented by the mean (± 
S.E.M.) o f six animals, obtained in normal PSS.
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Assessment of Denervation. Vasa deferentia that were chronically denervated 
and their paired controls were exposed to 100 pM tyramine in isolated organ baths 
and the contractile response recorded. Denervated tissues showed a time-dependent 
loss in responsiveness to tyramine (Fig. 9), with 2-day denervated tissues producing 
21,8 ± 5.2% of the control response (n-4, P < 0.001). Vasa denervated for seven 
days produced a contractile response that was 1.7 ± 0.7% of control (n**4, P < 0.001). 
The tyramine response was essentially the same for tissues that were denervated for 4- 
14 days and only those producing 10% or less of the control were considered 
sufficiently denervated to be used in the study.
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Figure 9. Tyramine response in control and paired! 2 or 7-day denervated rat vas 
deferens. ** indicate significant difference from control (P < 0.001).
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NE response in denervated vas deferens. In tissues that were chronically 
denervated for 6 -8  days, 10 pM NE was able to elicit 2,02 ± 0,3 g of contractile 
tension within 25 seconds (Fig. 10). The paired control tissues produced 0.63 ± 0.11 
g of maximal tension at the same time point (n-6 , P < 0.005). All tissues that were 
tested showed an initial large phasic response followed by a later tonic response of 
lesser magnitude. The tonic poition in the denervated tissues was significantly greater 
than that of control vas for up to 3 min of NE exposure (P < 0.05).
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Figure 10. Time-course of contractile force generated by denervated ( • )  and 
control (O) vas in response to 10 pM NE. Response in the denervated vasa were 
significantly greater than in controls at all points (P<0,05).
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Cumulative C-E curves to NE were produced in denervated tissues and 
compared to control responses to characterize the increased sensitivity of these tissues. 
The EQd for NE in denervated tissues was 5,5 X 10^ M while that in the control was 
9 X 10*7 M, an 18-fold shift in the C-E curve after denervation (Fig, 11), Cumulative 
additions of NE also resulted in 73.3 ± 8.7% greater contractile maximum in 
denervated than in the control vas (P < 0.01), The contractile responses to NE in 
denervated vasa were significantly greater than in the control at all concentrations of 
the agonist tested (P < 0.01).
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Figure 11. Concentration-effect curve to NE in 7-day denervated and paired 
control rat vas deferens. All denervated values were significantly different from 
control (P < 0.05).
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Response to NKA in denervated vas deferens. Construction of cumulative C-E 
curves to NKA in denervated and control vasa showed no significant alteration in the 
threshold concentration or EC50 of the two groups (Fig. 12). Moreover, there was no 
overall effect of denervation on the NKA response of the vas deferens as indicated by 
two-way analysis of variance (P > 0.1). None of the concentrations of NKA used 
produced a significantly greater response in the denervated tissue, as indicated 
Bonferroni's multiple-comparison test.
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Figure 12. Neurokinin A contractile response in control (A ) and denervated 
(*) rat vas deferens.
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Response to PDA in Denervated Vas Deferens. Cumulative additions of PDA 
to isolated organ baths produced significant contractile responses in both the control 
and denervated vas deferens (Fig. 13). In the presence of 10 pM phentolamine (an a - 
adrenergic receptor antagonist) and 20 mM K*-PSS, PDA produced concentration- 
dependent contractile activity in both tissue groups. However the responses obtained 
from ihe two groups were not significantly different. Contractile responses to single 
challenges of 2 pM PDA (in 20 mM K‘) were not significantly altered after 
denervation either (Table 1).
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Figure 13. Concentration-effect curve to PDA (20 mM K*-PSS) in denervated and 
control vasa.
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NE response in denervated vasa after nifedipine. Concentration-effect curves to 
NE were constructed in denervated and control tissues, before and after 10 min 
incubation with 100 nM nifedipine (a calcium channel blocker), The response to NE 
obtained after nifedipine was expressed as a percent of that before pretreatment with 
the channel blocker (Fig. 14), This concentration of nifedipine was selected as it 
significantly inhibited the contractile activity of both the denervated and control tissues 
in response to NE (P < 0.05) without completely abolishing it. The maximal 
contractile response to NE in the presence of nifedipine was 11.7 ± 1.0% (P < 0.001) 
and 34.8 ± 2.3% (P < 0.001) of the response before, in control and denervated tissues, 
respectively. Thus, nifedipine was able to inhibit 8 8 % of the NE response in control 
vasa whereas only 65% of the denervated tissue response was antagonized.
Figure 14. NE contractile response in denervated and control vas deferens before 
and after 100 nM nifedipine treatment. Responses to NE after nifedipine treatment, 
in each tissue, is expressed as a percent of the NE response before nifedipine 
exposure.
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Determination of Diacvlclvcerol Mass in Rat Vas Deferens 
DAG Mass bv Thin Laver Chromatography.
Denervated and control vasa were exposed to 100 pM NE in isolated organ 
baths under physiological conditions, for up to 10 min. The neutral lipids in the tissue 
were extracted in chloroform, and DAO and cholesterol resolved along with 
appropriate standards by thin layer chromatography. The lipids were visualized by 
charring on a hot plate (Plate 1) and quantified, relative to lipid standards, using Bio- 
Image analysis software.
The mass of DAG in each sample was divided by the mass of cholesterol in 
the same sample and expressed as ng of DAG per pg of cholesterol. Exposure of 
denervated and control vasa to 100 pM NE resulted in no significant change in free 
DAG from basal values at any of the time points determined (Fig. IS). Additionally, 
diacylglycerol mass was not significantly different between the two groups at any of 
the time-points compared.
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Figure 15. Diacylglyceiol mass determined in denervated and control vas deferens 
after stimulation with 100 |iM NE. Data are represented by the mean (± S.E.M.) for 
3*4 animals.
Plate 1 Thin layer chromatographic plate containing the cholesterol (column 1-5) and 
DAG (column 14-18) standards as well as lipid samples (column 6-13) from 
denervated and control vas deferens treated with NE for 10 min. For each sample a 
low and high amount were applied to the silica plate with the low amount being used 
to quantify the cholesterol content and the high sample used to determine DAG mass.
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DAG Mass in Control Vas Deferens bv HPLC,
Control vas deferens alone were exposed to 10 nM NE for 0-10 min under 
physiological conditions and the neutral lipids extracted from the tissue. DAG and 
MAG were separated and quantified by normal-phase HPLC. The mass of DAG and 
MAG were divided by the amount of cholesterol in the same sample and expressed as 
nmol/nmol cholesterol. Basal levels of DAG determined by HPLC (35 nmol/(imol 
cholesterol) were similar to those obtained by TLC (29 ng/jig cholesterol). As with 
the TLC experiments stimulation with NE for up to 10 min did not significantly alter 
the mass of DAG in the tissues (Fig. 16). The mass of MAG in the same samples did 
not accumulate significantly until after 5 min of exposure to NE.
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Figure 16. DAG ( • )  and MAG (O) levels in control vas after NE exposure. Lipid 
mass was determined by HPLC from 2 animals at each point.
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Molecular Species of DAG in Rat Vas Deferens.
The molecular species of DAG from denervated and paired control vasa were 
compared by reverse-phase HPLC to reveal any alteration in the source of DAG 
following denervation. Species of DAG from denervated and control vas deferens 
stimulated with 100 pM NE for 0, 1 and 10 min were compared.
All samples contained DAG lipids with similar retention times as the 18:0-18:1, 
16:0-16:0, 16:0-18:1, 18:1-18:1 and 18:0-20:4 DAG standards (Fig. 17). Exposure to 
NE for 10 min resulted in relatively higher amounts of the 18:0-20:4 DAG species in 
both control and denervated tissues. Chronic denervation of the vas deferens did not 
alter the relative amounts of the various species of DAG in resting or NE stimulated 
tissues (not shown).
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Figure 17. Molecular species of DAG from resting and NE stimulated (10 min), 
denervated rat vas deferens; separated by reverse-phase HPLC, The arrow indicates 
the position of 18:0-20:4 DAG.
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r’HlPhorboLDihutvrate Binding Studies
r3H1PPB Binding in Control Vas Deferens.
Control vasa were homogenized in 0.3 mM CaClj/1 mM MgCl2-containing 
MOPS and the particulate fraction (containing the plasma membrane) was assayed for 
PKC binding characteristics. The specific binding of the ligand was calculated from 
total binding by non-linear regression analysis (GraphPad InPIot, Fig. 18). A binding 
maximum (B ^ )  of 22.8 pmol/mg protein and dissociation constant (Kd) of 7.6 nM 
were obtained. Binding assays performed in the presence of 10 pM mezerein (to 
account for nonspecific binding) provided a B ^  of 27.9 pmol/mg and Kd of 9.8 nM.
Kd = 7.6 nM Total30ss,
M
1
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[3H]PDB Concentration (nM)
Figure 18. Specific binding of ^HIPDB to control rat vas deferens particulate 
calculated from total binding. Each data point is a mean of 2 replicates.
67
Specific binding of [3H]PDB was competitively displaced by unlabelled 
mezereln (Kd -  7 nM), PDB (Kd -  15 nM) and PDA (Kd -  500 nM) but not by the 
non-PKC activator, 4a-phorbol (Fig, 19).
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Figure 19. Competitive binding of mezerein (mez), PDB and PDA but not 4a - 
phorbol with pHJPDB, in control vas deferens.
PHIPDB Binding in Denervated Vas Deferens.
Control and paired, denervated vas deferens were prepared as indicated earlier 
and homogenized in Ca2*-free MOPS containing EDTA and GGTA. The particulate 
fraction was isolated and assayed. As indicated above, specific binding was calculated 
from total binding by non-linear curve fitting. The B ^  obtained from control and 
denervated samples were 4.8 ± 0.9 pmol/mg and 4.1 ± 0.4 pmol/mg of protein, 
respectively. The Kd values obtained from the two groups were also similar (Table 2),
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Table 2
Specific binding of []H]PDB in control and denervated rat vas deferens.
Whole rat vas deferens (denervated and paired control) were cleaned of extraneous 
tissue, incubated in PSS for 45 min and then challenged with 10 pM f4E. After 
thorough rinsing and a further equilibration period, all tissues were homogenized in 
2.5 ml MOPS containing 2.5 mM EDTA and 2 mM EGTA. The particulate 
fractions of the homogenates were isolated and pHJPDB binding assays performed 
on them.
Tissue Sample Bmu (± S.E.M.) Kd (± S.E.M.)
(n)
(pmol/mg protein) (nM)
CONTROL
4
4.8 ± 0.9 4.3 ± 0.6
DENERVATED
4
4.1 ± 0.4 3.5 ± 0.1
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Protein Kinase C Activity in Rnt Vas Deferens 
PKC activity in controi tissues.
Brain PKC activity has been characterized extensively (Nishizuka, 1988) and 
therefore initial studies were conducted to compare the relative amounts of PKC in the 
vas deferens. Samples of rat brain striatum and vas deferens were cleaned in cold, 
oxygenated PSS and incubated in Ca2*-free (EDTA/EGTA) MOPS buffer for 15 min. 
The tissues were homogenized in Ca^-free MOPS and particulate and cytosolic 
fractions were prepared. All samples were assayed for protein content and diluted to a 
concentration of 40 pg/ml before being assayed for PKC activity.
Protein kinase C activity in the brain cytosolic fraction was 16.3 ± 1.1 
nmol/min/mg protein (n»3) whereas that in the particulate was 5.6 ± 0.2 
nmol/min/mg (n-3 ), giving a cytosolic to particulate ratio of 2.9. The PKC activity 
was 10.9 ± 0.3 and 5.3 ± 0.4 nmol/min/mg protein (n**4) in the vas cytosolic and 
particulate samples, respectively. This provided a cytosolic to particulate activity ratio 
of 2.1 in the vas deferens. The cytosolic activity of PKC in the brain sample was 
significantly higher than in vas deferens (P < 0.05) but particulate activities were 
equivalent.
Effect of denervation on NE-induced PKC activation.
Whole vasa deferentia (paired control and denervated) were prepared as 
indicated previously, incubated under physiological conditions and stimulated with 1 0 0  
pM NE for 0-20 min. At various time-polnts of stimulation the tissues were quickly
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blotted on tissue paper and then homogenized in Ca2f-free MOPS.
The homogenates were separated into cytosolic and particulate fractions by 
centrifugation and following protein assay were diluted to 40 pg/ml of protein. The 
samples were assayed for total PKC activity as indicated earlier. Eight samples 
randomly selected from the particulate and cytosolic fractions were also assayed for 
activity In the absence of Ca2\  PMA and PS to determine the extent of 'nonspecific' 
phosphorylation activity in the assay.
Basal PKC activity of particulate and cytosolic fractions from denervated and 
control tissues were not significantly different. Stimulation of both denervated and 
control vasa with ME resulted in a time-dependent increase in particulate PKC activity 
with a concomitant decrease in cytosolic activity (Fig. 20 and 21).
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Figure 20. Effect of NE exposure on PKC distribution in control vas deferens. 
Each point is the mean (± S.E.M.) of 4 rats and * indicates significantly different 
from 0 min activity (P < 0.05).
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Figure 21. Effect of NE on PKC distribution in denervated rat vas deferens 
cytosolic and membrane fractions. Each point is the mean (± S.E.M.) of 4 animals. 
* indicates significantly different from 0 min values (P < 0.05).
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In membrane preparations from control vasa, PKC activity was significantly 
elevated by NG at 2, 5 and 20 min. The cytosolic activity of PKC from these tissues 
were not significantly different ftom basal levels for up to 20 min of NE stimulation.
For denervated tissues the particulate activity was significantly greater than 
basal values after 1,2, 5 and 20 min of NE stimulation (P < 0.05), and in the cytosolic 
samples PKC activity was only significantly altered at the 1 min point (P < 0.05). The 
maximal NE-induced PKC translocation to the membrane fraction was not different 
between the two groups, However, the maximal change was evident in denervated 
tissues within 5 min (Fig. 21) but was achieved only after 20 min in control samples 
(Fig. 20). Membrane PKCactivity in the denervated vasa was different ftom that in 
the paired control tissue at 2, 5 and 20 min after NE stimulation (Fig. 22, P < 0,05).
12
Denervated
Control
■ 1 . . . .  * . . . .  i . . . .  i
5 10 15 20
Time (min)
Figure 22. Time-course of PKC translocation to the membrane fraction of 
denervated and control samples after NE treatment. * indicates values significantly 
different from the paired control activity (P < 0.05).
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Cytosolic PKC activity was not different between the two groups at any of the 
time-points except 5  min, when difference in particulate activity between the two 
groups was maximal as well (compare Figs. 18 and 19). Activity in the absence of 
Ca2\  PMA and PS was 9.8 ± 0.5% and 21.9 ± 1.1% of total activity in particulate and 
cytosolic fractions, respectively (n -8 , significantly different, P < 0,005),
PKC activation bv other agents.
Particulate and cytosolic fractions from denervated and control vas deferens 
were prepared afier stimulation with 60 mM K*-containing PSS, 2 pM NKA or 2 pM 
PDB (in 20 mM K*-PSS). Treatment with each of these agents significantly increased 
PKC activity in the particulate fractions of all the samples (P < 0.01, Table 3) without 
significant alteration in cytosolic activity. Within each pair of denervated and control 
sample there was no difference in the PKC activities in response to the various 
agonists except that between cytosolic activity of PDB treated denervated and control 
vasa (P < 0.05).
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Table 3
Effect of K*-depolarization, NKA and PDB on PKC distribution in denervated and 
control rat vas deferens.
Denervated and control vasa were stimulated with 60 mM K*-PSS (for 2 min), 2 
NKA (for 2 min) and 2 pM PDB (in 20 mM K*-PSS, for 3 min) and cytosolic and 
particulate fractions prepared. Each of the fractions was assayed for PKC activity and 
compared to values obtained from unstimulated tissue samples. The data are 
represented by the mean (± S.E.M.) PKC activity of 3-4 animals (n).
Condition/Agonist Cytosolic Particulate
(nmol/min/mg) (nmol/min/mg)
Denervated/None 6.15 ±0.24 (4) 4.29 ±0.17 (4)
Control/None 7.44 ±0.24 (4) 3.34 ±0.44 (4)
Denervated/K* 5.96 ±0.38 (4) 12,77±1.06 (4)'
Control/K* 6,40 ±0,31 (4) 14.18±0.88 (4)b
Denervated/NKA 6.20 ±0,24 (4) 11.22 ±0.72 (3)'
Control/NKA 6.14 ±0.34 (4) 12.11±0.37 (4)b
Denervated/PDB 5.52 ±0.54 (4)c 12.85 ±1.86 (3)*
Control/PDB 6.64 ±0.38 (4) 13.9U1.09 (4)b
■* Significantly different from denervated/unstimulated or control/unstimulated 
values (P < 0.01), respectively.
c Significantly different from paired control tissues exposed to PDB (P < 0.05).
CHAPTER 4
Discussion
In the present study the role of protein kinase C (PKC) in mediating enhanced 
contractile response to receptor stimulation was examined. This enzyme has been 
shown to perform numerous cellular functions, including a role in the contractile 
activity of smooth muscle. In the smooth muscle of blood vessels, PKC activation 
results in contractile activity (Merkel et a l, 1991), whereas PKC inhibition antagonizes 
the contractile response to receptor agonists (NE and angiotensin II; Shibata et al., 
1990), The enzyme has also been implicated in the enhanced contractile response of 
blood vessels from spontaneously hypertensive rats (Turla and Webb, 1987; Bazan et 
al., 1992). Chronic denervation of the rabbit iris smooth muscle has also been 
associated with about 30% increase in cytosolic PKC activity (Akhtar and Abdel-Latif, 
1986).
An enhanced role for PKC in denervation supersensitivity was tested by 
comparing the contractile activities of a PKC activator (PDA) in denervated and 
control vas deferens. The amounts of diacylglycerol (DAG, the endogenous activator 
of PKC) produced in response to NE stimulation were also determined in control and 
denervated vas deferens, The binding characteristics of membrane-bound PKC to 
labelled PDB in denervated and control tissues were determined and an enzymatic
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method was employed to determine the ability of agonists to activate PKC in the two 
tissue groups.
Contractile Studies in the Vas Deferens
Normal Contractile Function and PKC
Exposure of the rat vas deferens to PDA or PDB in noimal P5S produced 
contractile response that varied from none to small and transient. The reason for this 
response may be that the resting concentration of intracellular calcium is below the 
threshold for PKC activation by phorbol esters. The activation of PKC requires free 
calcium and the phorbol esters or DAO appear to decrease the calcium requirement of 
the enzyme (Howe and Abdel-Latif, 1988). However, if the calcium concentration is 
below the threshold for this activation then the phorbol esters would be unable to 
stimulate kinase activity. This may explain why phorbol esters (PDA, PDB) were able 
to elicit significant contractile activity in the presence of depolarizing PSS (20 mM 
K*) which would presumably elevate intracellular calcium concentrations. In vascular 
smooth muscle phorbol esters alone are able to elicit a sustained response that may 
take up to an hour to develop maximally (Shibata et al., 1990; Merkel et al., 1991).
In Ca3*-ftee, depolarizing Tyrode buffer (80 mM K*), Baraban et al. (1985) obtained 
a contractile response of the vas deferens by addition of 1 mM Ca3* and 0.2 f M  PDA. 
Their results were obtained after prolonged exposure of rat vas deferens to non- 
physiological conditions, i.e. 80 mM K \ 0 mM Ca3* and 32°C bath temperature.
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In this study, responses to PDA and PDB were elicited after brief pre-exposure 
(1 min prior to phorbol agonists) to iso-osmolar PSS containing 20 mM K \ The 
ECjo estimated from the PDA concentration-effect curve (190 nM) agrees with that 
obtained by Baraban et al. (1985) and with the Kd for PDA binding to brain PKC 
(Konig et al., 1985) i.e.t 140 and 45 nM, respectively. As with receptor stimulated 
events, PDA and PDB (in the presence of 20 mM K*) produced a rapid phasic and a 
sustained tonic contractile response. This response was immediately reversed by 
rinsing tissues with fresh buffer and may indicate a membrane site for phorbol ester 
action. PKC appears to play the central role in the response to PDA and PDB 
because 4 a-phorbol, which is unable to activate PKC in vitro (Howe and Abdel-Latif, 
1988), was without effect in normal or 20 mM K*-containing buffer.
Inhibition of the K* plus PDA response by nifedipine would support the idea 
that K*-depolarization only augments the action of PDA by raising intracellular Ca3* 
concentration. It is also consistent with observations that phorbol esters only increase 
the affinity of PKC for Ca3* (Castagna et al., 1982; Howe and Abdel-Latif, 1988).
The failure of phentolamine and chronic denervation to inhibit the K* plus PDA 
response, indicates that neither a -adrenoceptor activation nor NE release from 
adrenergic nerves is involved in this response. It is unclear why OAO, a synthetic 
DAO, was unable to elicit a response in the rat vas deferens. Rapid metabolism and 
poor distribution through intact tissue may be the reason. PKC activation by OAO 
has mostly been demonstrated in cell-free systems (Howe and Abdel-Latif, 1988) or in 
dispersed cells (Kaibuchi et al., 1983).
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Pretreatment of the rat vas deferens with isoH-7 significantly inhibited 
contractile responses to NE and NKA. This agent has been shown to non- 
competitively inhibit PKC (Kischel et al., 1989; Ratz, 1990) presumably by interacting 
with the ATP binding site on the regulatory subunit of the enzyme (Hidaka et al.,
1984). However, the inhibitory action of this compound on other cellular kinases (e.g. 
MLCK) are not known and cannot be ruled out.
The application of isoH-7 markedly attenuated the maximal phasic and 
subsequent tonic response to 60 mM K* in the rat vas deferens. This result is 
consistent with reports that high extracellular K* causes PKC translocation and 
activation (Ho et al., 1988; Haller et al., 1990). These responses are most likely 
mediated by the influx of CaJf via voltage-dependent calcium channels and subsequent 
rise in intracellular Ca2\  The ability of CaJ* to activate PKC in the presence of 
phosphatidylserine alone (Howe and Abdel-Latif, 1988) and its ability to convert 
membrane-associated PKC to the membrane-inserted form (Huang, 1989) would also 
support the idea of PKC activation by high K \ It is unlikely that feoH-7 antagonizes 
the K* response by inhibiting Caa* influx since Shibata et al. (1990) and Merkel et 
al. (1991) reported no influence of &oH-7 on the KMnduced 45Ca influx in vascular 
smooth muscle.
In normal buffer, 10 min pretreatment of the vas deferens with PDA resulted in 
no change in the onset or ECj<, of subsequent NE-induced contractile responses. The 
maximal contractile force in response to NE was enhanced by PDA pretreatment in 
each tissue tested, but the overall result was found to be statistically non-significant.
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This may indicate that the statistical analysis procedure used (Bonferroni's post-test for 
multiple comparisons) was too stringent. In the rat vas deferens Baraban et al. (198S) 
reported significant enhancement of the contractile response to a single NE (20 juM) 
challenge by 2-3 min pretreatment with PDA, However, we were not able to 
reproduce this result in our experiments using single NE challenges and similar 
incubation times.
Denervation Supersensitivitv in the Vas Deferens
Vas deferens that were chronically denervated for 0 ,2  and 7 days showed a 
time-dependent loss in tyramine-stimulated contractile response. This loss in tyramine 
response is very similar to the time-dependent loss in NE content of the denervated 
tissues (Kasuya et al., 1969; Rice et al., 1987) and consistent with the degeneration of 
adrenergic nerve endings after chronic denervation (Gordon-Weeks and Gabella,
1977). Birmingham (1970) also reported similar loss in tyramine response after 
denervation of the rat vas deferens.
Chronic denervation of the vas deferens resulted in tissues that produced an 
initial phasic and subsequent tonic contractile response to NE, much like the response 
in control tissues. However, exposure of the tissue to a single concentration of NE 
resulted in a maximal phasic response in denervated vasa that was 320% of the control 
response. Since the time to maximal response was essentially the same in both 
groups, the data would suggest a greatly increased rate of contractile force production 
after denervation. Hie later tonic response to NE was also significantly greater in the
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denervated vas for up to 3 min of NE stimulation. The equivalent time to maximal 
force after denervation also argues against the hypothesis that better diffusion of NE 
through the tissue to the receptor sites is a factor mediating the supersensitivity 
response (i.e. a prejunctional phenomenon).
Cumulative additions of NE revealed that denervated vasa were about 18-fold 
more sensitive to the stimulatory action of the agonist when compared to control 
tissues. The maximum force generated by cumulative NE addition was also 
significantly greater in the denervated as compared to the control tissues. Much of the 
decrease in threshold concentration for contraction in the denervated vasa appears to 
be due to the loss of intact adrenergic nerve terminals. This would result in greatly 
reduced uptake of exogenously applied NE, resulting in higher effective concentrations 
of NE at the receptor (prejunctional effect). This action may be demonstrated by 
pretreating control vasa (having intact nerve endings) with NE uptake (cocaine and 
hydrocortisone) and metabolism (U-0521) inhibitors before production of C-E curves 
(Abraham and Rice, 1992a). The result is a 6 -fold decrease in the ECg, of the NE 
response without a change in the maximal response.
The largest component of the shift in the NE curve after denervation would 
thus be due to the loss in neuronal uptake of applied NE. The remaining 3-fold shift 
in the denervated tissue response would be due to postjunctional alteration in tissue 
response to the agonist. The enhanced maximal response to single concentrations, as 
well as cumulative additions of NE, are consistent with the development of significant 
postjunctional supersensitivity in the rat vas deferens.
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NKA Response in Denervated Vas Deferens
Neurokinin A, which produces a maximum contraction equivalent to NE in 
normal vasa, did not reveal a significant increase in sensitivity of the tissue after 
chronic denervation. Hie EC*, and maximal force developed were not significantly 
different between denervated and control tissues, when compared by analysis of 
variance. This lack of effect may reflect some basic difference in the coupling of the 
neurokinin receptor (NK-2, Osakada et a l, 1986) to the contractile apparatus as 
compared to the a-adrenoceptor. Thus denervation would result in enhanced coupling 
of certain receptors (cc1( angiotensin and acetylcholine) but not others (NK-2), to the 
contractile apparatus.
An alternate explanation for the lack of supersensitivity to NKA may be that 
the cumulative additions of the agonists resulted in short-term desensitization of the 
receptors. In this case non-cumulative exposures to NKA, with rinsing of tissues in 
between additions, may more faithfully depict changes in response after denervation. 
Support for short-term desensitization may be obtained from the NE response, where 
the single challenge of NE produced a 320% greater response in denervated relative to 
control tissues. The cumulative curve to NE only showed a 178% increase in maximal 
response. However, any desensitization that may result from cumulative addition of 
NKA would be short-term because the vas deferens is able to produce two very 
similar NKA cumulative curves when separated by a 45 minute wash and equilibration 
period.
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PDA Response in Denervated Vas Deferens
Phorbol diacetate (PDA) was able to elicit significant, concentration-dependent 
contractile activity of the denervated rat vas deferens in 20 mM IC-PSS. However 
this response to PDA was virtually identical to that obtained in the paired, control 
vasa. Responses to single challenges of PDA (2 pM) were not significantly different 
between the two groups.
The lack of an enhanced response in denervated tissues would indicate that 
PKC activation by K* plus PDA is not significantly different in the two tissues. In 
addition, this result would also argue against increased nexal contacts as mediating the 
supersensitivity response, because this hypothesis predicts that all agonists will elicit 
an enhanced response.
NE ResponseJn Denervated Vasa after Nifedipine
Cumulative C-E curves to NE were produced in control and denervated vas 
deferens before and after treatment of the tissues with nifedipine. This treatment 
eliminated about 8 8 % of the subsequent NE response in control tissues, whereas only 
about 65% of the response in denervated vasa was abolished. These data are 
consistent with control tissues being more dependent on extracellular Ca1* in producing 
contractile tension, as compared with denervated tissues. The denervated tissues may 
be more dependent on Cal* mobilized from intracellular sources via IPj-sensitive or 
other mechanisms.
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These results do not exclude the possibility that the net cytoplasmic 
concentrations of Ca3* are the same in the two tissue groups during receptor 
stimulation, but that the contractile proteins become more sensitive to the cation after 
denervation. Ramos et al. (1986) demonstrated that the denervated guinea pig vas 
deferens was more sensitive to the rise in cytosolic Ca3f than control vasa. In Tritonx- 
100-permeabilized guinea pig vasa, cumulative additions of Ca1* revealed that 
denervated tissues were 1.5-fold more sensitive to the contractile effect of Ca2’as 
compared to control vasa. These authors also observed an increased rate of tension 
development to Ca3* in the denervated vas.
Diacvlglvcerol Mass in Rat Vas Deferens
DAG Mass bv Thin Laver Chromatography
Denervated and control vasa treated with NE for up to 10 min showed no 
significant change in DAG mass from basal levels as determined by TLC. Using such 
a chromatographic method Takuwa et al. (1986) were able to show significant 
elevation of DAG mass after stimulating bovine tracheal muscle strips with carbachol. 
However, Rembold and Weaver (1990), studying the effect of histamine and 
endothelin in swine carotid artery muscle strips, reported no change in DAG mass as 
assayed by the DAG kinase method.
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Exposure of both denervated and control vasa to NE appeared to cause a small, 
transient decrease in DAG mass but this was not found to be statistically significant. 
DAG mass at all time points of NE stimulation were essentially the same in the two 
tissue groups.
These results are consistent with those reported by Takenawa et al. (1983) and 
Minneman et al. (1988), who observed no significant difference in PIP2 hydrolysis 
between denervated and control vas deferens after NE stimulation. However 
Takenawa et al. (1983) did report a significant accumulation of phosphatidic acid (PA) 
in denervated vasa after NE stimulation for 3 min. Since about a third of cellular 
DAG is metabolized to PA by DAG kinase (Majerus et al., 1986), this study was 
undertaken to determine if DAG from PIP2 hydrolysis was the source of the elevated 
PA levels. The results suggest that the elevation in cellular PA has a source other 
than DAG, Membrane-bound phospholipase D has been shown to hydrolyze 
phosphatidylcholine to PA (Lassegue et al., 1993) and thus elevated PA levels after 
denervation may indicate an enhanced coupling of a-adrenoceptors to 
phospholipase D. However the implications for such an alteration in receptor coupling 
to contractile function is not clear.
DAG Mass in Control Vas Deferens by HPLC
Using the HPLC technique the mass of DAG in control vas deferens was 
determined after stimulation with NE. The mass of monoacylglycerol (MAG) in the 
same tissues were simultaneously measured, The basal DAG levels were very similar
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to those obtained by thin layer chromatography. Exposure of the vas deferens to NE 
for up to 10 min resulted in no significant accumulation of DAO but rather a small, 
transient decrease in mass was observed again. The lack of measurable DAG 
accumulation in vasa after NE stimulation as determined by both TLC and HPLC 
methods would suggest the observation is not due to limitations in the methods 
employed. The initial decrease in DAG mass may be due to increased metabolism or 
decreased PIP2 hydrolysis. This initial decrease in DAG mass was accompanied by 
similar decreases in MAG; thus, transient loss in DAG is not due to increased 
metabolism to MAG. However, after longer periods of NE stimulation (greater than 5 
min), MAG began to accumulate rapidly; this is consistent with DAG levels being 
held in check by rapid metabolism to MAG (Majerus et al., 1986).
Molecular Species of_DAG in Rat^asJ3eferens
The molecular species of DAG were determined in denervated and control vas 
deferens that were at rest or stimulated with NE for 1 or 10 min. The various species 
of DAG in denervated and control samples appeared identical by HPLC. Resting 
tissues contained DAG lipids with similar retention times as l-stearoyl-2-oleolyl 
glycerol, 1,2 -dipalmitoyl glycerol, l-palmitoyl-2 -oleoIyI glycerol, 1,2 -dioleoyl glycerol 
and l-stearoyl-2-arachidonyl glycerol standards. With receptor stimulation the relative 
proportion of the 18:0*20:4 DAG (mainly from PIP] hydrolysis) was increased, This 
result is consistent with PIP2 hydrolysis after a,-receptor activation in the vas, which 
would result in IP, (Minneman et al., 1988) and 18:0-20:4 DAG (Howe and Abdel-
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Latif, 1988) formation. However, this is In apparent contradiction with the earlier data 
that showed no change in total DAO mass either by TLC or HPLC methods. This 
discrepancy may be due to increased metabolism of total DAQ as well as 
accumulation of 18:0-20:4 DAG upon receptor stimulation, the net result being little or 
no change in total DAO mass.
This portion of the study was carried out to determine if the source of DAG 
production had changed after chronic denervation of the vas deferens. The hypothesis 
was that PIP} hydrolysis would remain unchanged but DAG mass would be 
significantly increased due to coupling of the receptor to hydrolysis of other membrane 
phospholipids (e.g. phosphatidylcholine). Evidence for this type of dual coupling of 
the same receptor to different phospholipases has been presented by Plevin et al.
(1991) and Lass£gue et al. (1993). Such an alteration would have resulted in 
formation of additional DAG species other than 18:0-20:4, however, the evidence 
obtained does not support this hypothesis. The results from the present study, along 
with prior data from other labs, would indicate that denervation does not cause an 
enhanced coupling of o,-receptors to PIP2 hydrolysis.
PHlPhorbol Dibutvrate Binding Studies
f^HIPDB Binding in Control Vas Deferens
In this study the binding characteristics of membrane-bound PKC were 
determined using the specific ligand fH]PDB. Control vasa homogenized in Ca3>-
87
containing MOPS buffer produced specific and saturable binding of [3H]PDB. The Kd 
values obtained in the present study (3-9 nM) agree well with those obtained for 
[JH]PDB binding in mouse brain particulate fraction (7 nM; Dunphy et al., 1980), 
mouse brain cytosolic fraction (4 nM; Sharkey et al,, 1984), rat pituitary cells ( 8  nM; 
Jaken, 1985) and EL4 mouse thymoma cells (11 nM; Sando et al., 1982).
The specific binding of the ligand was also reversible and could be displaced 
by increasing concentrations of mezerein, unlabelled PDB and PDA. The non-PKC 
activator 4o-phorbol was not able to displace [3H]PDB binding which suggests that 
this compound does not bind to PKC. This agrees with the findings of Howe and 
Abdel-Latif (1988) who reported no PKC activation by 4cc-phorbol, and Dunphy et al. 
(1980) who were unable to displace pH] PDB binding with a 4a-phorbol derivative in 
mouse brain. This also explains the lack of contractile response to 4et-phorbol in the 
rat vas deferens when compared to PDA and PDB.
j’HlPDB-Binding.in.Deneryated Rat Vas Deferens
There was no significant difference in the specific binding characteristics of 
pH]PDB binding between chronically denervated and the paired control vasa. The Kds 
obtained from this study were similar to those obtained by other groups. The B ^  for 
binding was not altered by denervation either. The similarity between the PKC 
binding characteristics of the two samples argues against an increased affinity of PKC 
for its endogenous activator (DAO) or elevated resting levels of the enzyme at the 
membrane mediating the supersensitive response.
Protein Kinase C Activity in Rat Vas Deferens
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PKC Activity in Control Vas Deferens.and Brain
The PKC assay kit utilized the transfer of J1P, from [3IP]ATP to the substrate 
peptide (EGF receptor peptide) by the PKC in the sample. The PKC activity in rat 
striatal cytosolic samples was about l.S times greater than in vas deferens, whereas the 
activities in the particulate fractions from the two tissues were much the same. The 
ratio of cytosolic to particulate activity was almost 3 for brain samples and 2 for vas 
deferens. This activity ratio in the vas deferens was much smaller if the tissue was 
not homogenized in Ca3f-free conditions, due to a calcium artifact of PKC adhering to 
the membrane preparations. Since the reported values of PKC activity vary greatly 
due to the assay conditions used by different laboratories, the brain samples were used 
as a standard with which to compare the relative amounts of PKC in the vas deferens. 
Considering that the brain has the highest reported amounts of PKC (Nishizuka, 1988), 
the vas deferens appears to have significant amounts of the enzyme (67% of brain 
activity).
Effect of Denervation on NE-induced PKC Activation
The basal activities of PKC in the cytosolic and particulate fractions from 
denervated and control vasa were not significantly different. This result is comparable 
to that obtained in the binding assays, with about 4 pmol/mg of PKC resulting in 
about 4 nmol P( transferred per min per mg protein; an effective PKC activity of about
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1000 molecules of P( transferred per min per mol of enzyme. Vas deferens that were 
exposed to NE displayed a time-dependent increase in membrane-associated PKC 
activity with accompanying decreases in the cytosolic activity. This result is 
consistent with PKC translocating to the membrane from the cytoplasm during 
receptor stimulation. Much the same results were obtained by agonist activation of 
smooth muscle strips from bovine trachea (Langlands and Diamond, 1992); swine 
carotid arteTy (Singer et al., 1992); bovine carotid artery (Haller et al., 1990) and rat 
aoria (Bazan et al,, 1992). However, the absolute values reported in these studies vary 
widely owing to differing assay conditions and tissues.
In denervated vasa the PKC translocation during receptor stimulation was 
maximal within 5 min of NE stimulation and remained elevated for up to 20 min of 
stimulation. In contrast, PKC activation in control vas deferens developed more 
slowly and reached maximum only after 20 min of NE stimulation. Longer 
stimulation times with NE were not carried out in either tissue group. This result is 
consistent with an increased rate of PKC activation in the denervated tissues relative to 
the control response. Since the amount of DAG is not significantly altered during 
receptor activation it would appear that intracellular Ca3\  and not DAG, mediates the 
translocation of PKC to the membrane in the vas deferens. A more rapid change in 
cytosolic CaJ* would result in faster activation of PKC which could be in place to 
augment the receptor-mediated contractile activity.
The PKC activity in the particulate and cytosolic samples assayed in the 
absence of Ca3\  PM A and PS were about 10 and 22% of total activity, respectively.
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This small but significant phosphorylation activity in the absence of the cofactors for 
PKC would imply the presence of a second protein with similar kinase properties for 
the substrate peptide. According to the information in the PKC assay kit protein 
kinase A, phosphorylase kinase and the proteolytic fragment of PKC (Ca3\  PMA and 
PS independent) are able to generate 8,13 and 38% of the PKC activity, respectively. 
Additionally, myosin light chain kinase and hexokinase were not found to have any 
activity when assayed with the kit. The Ca3*, PMA and PS-independent activity could 
be due to any or a combination of the active proteins that are found in this tissue.
Brain cortex samples assayed with the kit also provided similar amounts of nonspecific 
phosphorylating activity.
PKC Activation bv Other Agents
Denervated and control vas deferens exposed to high K*, NKA and PDB also 
exhibited significant PKC translocation to the membrane fraction, when compared to 
their respective unstimulated tissues. This data is similar to that obtained for K*- 
induced (Ho et al., 1988; Haller et al., 1990) and PDB-induced (Haller et al., 1990; 
Singer et al., 1992) PKC translocation in various tissues.
The activation of PKC between denervated and control tissues by these 
contractile agents was not significantly different. This is consistent with the lack of 
supersensitlve contractile response in denervated vasa after high K*, NKA or phorbol 
ester stimulation. Hie ability of K* to produce PKC translocation also suggests a 
mechanism by which PKC inhibitors are able to antagonize the contractile response to
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K*-depolarization. It may also indicate that the rise in intracellular Ca3* is the primary 
signal for PKC translocation (Ho et al., 1988),
Cytosolic activities of PKC after treatment with these contractile agents were 
not significantly different from the respective untreated tissues. The activity of the 
enzyme in the denervated sample after PDB, however, was significantly lower than 
that in the paired, control sample. The relevance of this result is not readily apparent, 
There is considerable evidence that PKC is able to perform multiple functions 
in cells, which makes it difficult to correlate its activity with a complex event such as 
muscle contraction. Direct biochemical studies have described an inhibitory role for 
the enzyme on PIP2 hydrolysis and MLCK-medlated phosphorylation of MLC 
(Nishikawa et al., 1984; Itoh et al., 1988; Leeb-Lundberg et al., 1985). Calcium 
fluorescence studies have also shown PKC to decrease the amplitude of the 
intracellular Ca3* spike after agonist stimulation (Itoh et al., 1988). The enzyme has 
been implicated in activating the Ca3*-ATPase pump on the plasma and sarcoplasmic 
membrane (Fukuda et al., 1990). Such an action will have the effect of extruding 
cytoplasmic CaJ* to the extracellular space as well as increasing its sequestration into 
the sarcoplasmic reticulum.
There is also evidence to support a positive role of PKC on smooth muscle 
contraction. Itoh et al. (1988) showed that even though the intracellular CaJf spike 
after receptor stimulation is depressed by PKC activation, significant attenuation in 
contractile activity does not result. The authors ascribe a role for PKC in sensitizing 
the contractile elements to Ca3* which leads to equivalent response in the presence of
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lowered Ca1*. This is consistent with the report by Baraban et al. (1985) where PKC 
activation (by phorbol esters) augments the receptor-mediated contractile event. 
Additionally, Souhrada and Souhrada (1989) and Mironneau et al., (1991) have 
presented evidence to support PKC-medlated Ca2* influx into smooth muscle cells.
With PKC playing both inhibitory and stimulatory roles in smooth muscle, it is 
conceivable that these processes are chronologically separated. Thus short term PKC 
activation could result in positive PKC effects whereas long term activation leads to 
negative feedback effects. If such a scenario exists, then a more rapid 
translocation/activation of PKC in denervated vas deferens would put the enzyme in a 
position to effect positive actions with the normal contractile apparatus.
The existence of PKC isozymes adds further complexity to the role of the 
enzyme in situ; particularly with regard to the Ca37phospholipid-independent and 
dependent forms. It is possible that the total amount of the enzyme remains 
unchanged after denervation of the vas deferens, but the relative amounts of the 
various isozymes becomes altered. Singer et al. (1992) and Khalil et al. (1992) have 
characterized 5 isozymes of PKC in smooth muscle; three of which are Ca2*-sensitive 
(a , p and y) and the rest CaJ*-insensitive (e and ()• Denervation of the vas deferens 
may trigger a shift in the PKC population from the Ca2*-sensitive to the insensitive 
forms. Thus the PKC-mediated effects may become more apparent at lower cellular 
Ca’* concentrations. This would result in PKC-mediated events being less dependent 
on Ca1* in the supersensitive vas deferens. The greater than normal response of
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denervated vasa to NE after nifedipine is consistent with such a decrease in the Ca3* 
requirement for contractile response.
Ultimately the enhanced contractile response in the denervated rat vas deferens 
probably reflects an increased number of actin-myosin crossbridges formed during 
receptor stimulation. Such an increase would be mediated by: (i) increased 
mobilization of Ca3* by receptor-mediated events; (ii) increased sensitivity of the 
contractile proteins to Ca3*; (iii) decreased MLC phosphatase activity which is 
responsible for dephosphorylation of MLC and relaxation of muscle; or (iv) some 
combination of the three processes working in concert. Of the three major 
mechanisms, PKC has been implicated in sensitizing the contractile proteins to Ca3* as 
well as decreasing MLC phosphatase activity (Somlyo and Himpens, 1989). The 
results obtained herein support a positive role for PKC in the supersensitive response, 
but not necessarily as the sole mediator. The net enhanced response of the denervated 
vas deferens is most likely a culmination of several cellular processes in adaptation to 
the loss in neuronal input. Eventually, elucidation of the mechanism of the 
supersensitivity phenomenon will provide information as to how smooth muscle cells 
adapt to receptor signalling, as well as provide evidence that neurotransmitters such as 
NE are not just contractile agonists but also regulators of primary cellular function 
with regard to gene expression, protein synthesis and metabolic activity.
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CHAPTER 5
Summary and Conclusions
1. The ability of PKC activators, such as PDA and PDB, to elicit contractile 
response in the rat vas deferens indicates a role for protein kinase C in the production 
as well as the maintenance of muscle contraction in this tissue. The effect of PKC 
inhibition leading to depressed receptor and non-receptor-induced contraction would 
attest to a fundamental role of PKC in the contractile activity of the normal vas 
deferens.
2. The markedly enhanced response to norepinephrine in the denervated rat vas 
deferens is indicative of the development of supersensitivity in this tissue. The 
inability of NKA and PDA to elicit an increased response after denervation may point 
to a difference in the way these agents produce a contractile response, relative to NE. 
The effect of nifedipine antagonizing the NE response in control tissues to a greater 
extent than in denervated vasa, is further support for a postjunctional alteration leading 
to the supersensitive response. It is also consistent with a change in the source for 
Ca3* utilized for muscle contraction after denervation.
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3. Stimulation of denervated and control vas deferens by NE resulted in no 
significant accumulation of the second messenger diacylglycerol. This may be due to 
rapid metabolic processes that lead to near constant amounts of tissue DAO. The 
molecular species of DAG found in denervated tissues were the same as those in 
control vasa and provide support for a lack of change in the coupling of a-receptors to 
multiple phospholipases. Rather the receptor appears to be linked to PIP2 hydrolysis 
in both denervated and control tissues.
4. Chronic denervation of the rat vas deferens led to no change in the amount or 
binding affinity of membrane-bound PKC. Thus the supersensitive response is not 
mediated by an increased basal level of membrane-bound PKC or caused by its 
enhanced affinity for activators, phorbol esters or DAO.
5. NE was able to activate PKC at a faster rate in the denervated vas when 
compared to the control response. This alteration may result in PKC being in a 
position to more readily augment the Ca3*-mediated contractile function of the tissue. 
Neurokinin A, PDB and K*-depolarization produced equivalent PKC translocation in 
denervated and control vasa and this is consistent with the similar tissue 
responsiveness to these agents after denervation.
6. The ability of NE to cause PKC translocation in the rat vas deferens without 
increasing DAG levels would indicate that DAG is not the primary mediator of this 
process. In addition, basal levels of DAG in the tissues were found to be sufficient to 
activate at least 50 times the PKC that became associated with the membrane after 
receptor stimulation (assuming a mol per mol interaction of DAG and PKC).
7. The change in the rate of PKC activation and Ca3*-dependence may eventually 
point to a changing role of Ca1* in mediating contractile response in the supersensitive 
vas deferens, Assuming the tension developed by smooth muscle is proportional to 
the number of actin-myosin cross-bridges formed, the supersensitive response would 
be indicative of an increase in such an interaction. This increase in actin-myosin 
interaction could be mediated by: (i) increased mobilization of Ca1*; (ii) increased 
sensitivity of the contractile proteins to Ca3*; (ill) decreased rate of dephosphorylation 
of MLC; or (iv) a combination of these three events. Of these possible events this 
study provides evidence for increased intracellular Ca1* mobilization and for PKC in 
increasing the sensitivity of contractile processes to Ca3*. Thus a direct role for PKC 
in mediating the supersensitive response merits further investigation.
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8. Thus far, the study of denervation supersensitivity has progressed from the 
level of the receptor toward the intracellular events mediating contractile function. It 
may be more efficient to begin further studies from the more fundamental interactions 
of actin and myosin and design the process outward. The increased rate of contractile 
force production after denervation warrants the study of MLC phosphorylation 
following receptor activation in these (issues. The maximal phasic force produced 
should be proportional to the amount of MLC phosphorylated. A significant deviation 
from this relationship would point to secondary processes (increased Ca1* sensitivity 
or involvement of other cytosolic proteins such as desmin, caldesmon, etc.) playing a 
more prominent role in the supersensitive tissue. The altered sensitivity to Ca1* 
channel blockers in denervated tissues may reflect a change in the sensitivity of the 
contractile apparatus to Ca1*. Contractile studies with the denervated, skinned muscle 
preparation could provide evidence for such an alteration. Such a pursuit may 
eventually reveal differences in the regulation of smooth muscle after denervation and 
provide new insights into cell signal regulation.
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Appendix A
Physiological Salt Solution
Reagents
Stock A (10X concentrate)
Molecular Wt. Mass (g)
Sodium Chloride 58.44 132.00
Potassium Chloride 74.56 7.08
Calcium Chloride*2HiO 146,99 7.41
Magnesium Sulfate* 7 H2O 246,48 5.88
Dextrose 180.16 20.00
dissolve in distilled water 2000 ml
Stock B (10X concentrate)
Molecular Wt. MassJg)
Potassium Hyd. phosphate 136.09 3.22
Sodium bicarbonate 84.01 42.00
dissolved in distilled water 2000 ml
Procedure
1. To make 2 1 of PSS, 200 ml of stock A and B are added in a volummetric 
flask and brought up to volume with distilled water.
2. Addition of distilled water (about 400 ml) between the mixing of stock 
solutions prevents precipitation of calcium salts.
Ill
3. The PSS Is aerated with 5% carbon dioxide in oxygen for about 30 min before
use.
PSS Comuosition Final Concentration fmM)
NaCl 112.94
KC1 4.75
CaCl2 2.52
MgS04 1.19
Dextrose 5.55
k h 2p o 4 1.18
NaHCOj 25,00
jncentrations
Na* 137.9 mM Cl* 122.7 mM
K* 5.9 mM PCV* 1.18 mM
Ca1* 2.52 mM HCOj- 25.0 mM
Mg1* 1.19 mM
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Appendix B
High K*-containinE PSS
Reagents
Stock A (10X concentrate)
Molecular Wt. Massis)
NaCl 58.44 7.54
KG 74.56 74.56
GaGx*2HaO 149.99 3.71
MgSoWHjO 246.48 2.94
Dextrose 180.16 10.00
dissolve in distilled water 1000 ml
Stock B (10X concentrate)
Molecular Wt. Mass fg)
k h 2po 4 136.09 1.61
NaHCOj 84.01 21.00
dissolve in distilled water 1000 ml
Procedure
1. To make 100 mM K*-PSS (11) add 100 ml of stock A, dilute with about 200 
ml off distilled water and then 100 ml of stock B in 1000 ml volummetric 
flask. Bring up to the mark with distilled water.
2. To make 100 ml of 20 mM K*-PSS, the above solution is diluted with regular 
PSS according to the formula:
113
[K >100 ml -  {100 mM K*« X ml) + 5.9 mM (100 - X ml), 
which reduces to:
X -  {[K*] - 5.9J/0.94,
where [K*] is the desired K* concentration and X is the volume of 100 mM K* 
to be diluted.
Thus 15 ml of 100 mM K*-PSS is mixed with 85 ml of regular PSS to obtain 100 ml 
of 20 mM K*-PSS.
Appendix C 
Lowry Protein Assay
114
Reagents 
Reagent A:
Sodium carbonate (2.00%) lO.OOg
Sodium dodecyl sulfate (0.50%) 2.50g
Potassium sodium tartrate (0.02%) O.lg
Sodium hydroxide (0.10 N) 2.0g
dissolve in distilled water 500 ml
Reagent B: Copper sulfate.5H20  (0,5%, w/v)
Reagent C: Mix 50 ml of Reagent A and
1 ml of Reagent B
Reagent D: Folin and Ciocalteau reagent
diluted with equal volume of distilled water
Procedure
1. Sample containing 10-150 pg of protein in 400 pi volumes are used,
2. Add 2 ml of Reagent C and mix well. Allow the mixture to stand at room 
temperature for at least 10 min.
3. Add 200 pi of Reagent D and vortex immediately. Allow to stand for at least 
30 min at room temperature.
4. Read the absorbance of the mixture in a spectrophotometer at 750 nm, against 
appropriate blank mixture.
With each Lowry assay protein standards (bovine serum albumin) are also 
assayed. Typically 10-150 pg of BSA are assayed by the same procedure to 
produce a standard curve. The curve of Absorbance^ versus protein content 
(BSA) is plotted and used to calculate the protein content in the unknown 
samples. This is done by the use of GraphPad's linear regression procedure.
Typical standard curve to BSA using the Lowry 
protein assay
1,00
I o ! °oc
0.25
<
0.00
75 100 125 150 175
BSA content (ug)
Figure 23. Data represents the mean (± S.E.M.) of 4 replicates with 
linear regression line. The dotted line indicates the 95% confidence 
interval.
Appendix D
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Bio-Rad Protein Assay
Reagent
Bio-Rad Protein assay dye reagent concentrate 
diluted 1:5 with distilled water.
Procedure
1. Aliquots of the samples (100 pi) containing 10-150 pg of protein are used.
2. Add 5 ml of the diluted dye reagent and mix by shaking.
3. Allow to sit at room temperature for at least 5 min but not longer than 1 hour.
4. Read the absorbance of the mixture in a spectrophotometer at 595 nm against
appropriate blanks.
5. Standard protein amounts of bovine-y-globulin (10-200 pg/100 pi) are also 
assayed at the same time.
A standard curve for bovine gamma globulin is produced by plotting the 
Absorbance^ versus the protein content of the standard. BSA is generally not 
used as a standard due to the high amounts of color developed, thus 
underestimating the protein in the samples.
This assay was used in the current study to assay for protein in buffers 
containing EDTA and EGTA, which give very high blanks when assayed with 
the Lowry method.
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Standard curve for bovlne-t-gtobulin using the 
Bio-Rad protein assay reagent
is
0.8*
g 0.6 
I  0.4
in
A
<  02
0.0
150100
Protein content (ug)
20050
Figure 24. Data are represented by the mean (± S.E.M.) of 3 replicates. The 
dotted lines are the 95% confidence interval of the regression line.
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